<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net" />
<link rel="shortcut icon" href="https://www.biorxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes" />
<meta name="type" content="article" />
<meta name="category" content="article" />
<meta name="HW.identifier" content="/biorxiv/early/2017/08/29/182196.atom" />
<meta name="HW.pisa" content="biorxiv;182196v1" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity" />
<meta name="DC.Identifier" content="10.1101/182196" />
<meta name="DC.Date" content="2017-08-29" />
<meta name="DC.Publisher" content="Cold Spring Harbor Laboratory" />
<meta name="DC.Rights" content="© 2017, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission." />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="Coronaviruses (CoV) are positive-sense RNA viruses that infect numerous mammalian and avian species and are capable of causing severe and lethal disease in humans. CoVs encode several innate immune antagonists that interact with the host innate immune response to facilitate efficient viral replication. CoV non-structural protein 14 (nsp14) encodes 3'-to-5' exoribonuclease activity (ExoN), which performs a proofreading function and is required for high-fidelity replication. Outside of the order Nidovirales , arenaviruses are the only RNA viruses that encode an ExoN, which functions to degrade dsRNA replication intermediates. In this study, we tested the hypothesis that CoV ExoN may also function to antagonize the innate immune response. We demonstrate that viruses lacking ExoN activity [ExoN(-)] are sensitive to cellular pretreatment with interferon beta (IFN-β) in a dose-dependent manner. In addition, ExoN(-) virus replication was attenuated in wild-type bone marrow-derived macrophages (BMMs) and partially restored in interferon alpha/beta receptor deficient (IFNAR-/-) BMMs. ExoN(-) virus replication did not result in IFN-β gene expression, and in the presence of an IFN-β-mediated antiviral state, ExoN(-) viral RNA levels were not substantially reduced relative to untreated. However, ExoN(-) virus generated from IFN-β pretreated cells had reduced specific infectivity and decreased relative fitness, suggesting that ExoN(-) virus generated during an antiviral state is less viable to establish a subsequent infection. Overall, our data suggest MHV ExoN activity is required for resistance to the innate immune response and antiviral mechanisms affecting the viral RNA sequence and/or an RNA modification act on viruses lacking ExoN activity." />
<meta name="DC.Contributor" content="James Brett Case" />
<meta name="DC.Contributor" content="Yize Li" />
<meta name="DC.Contributor" content="Ruth Elliott" />
<meta name="DC.Contributor" content="Xiaotao Lu" />
<meta name="DC.Contributor" content="Kevin W. Graepel" />
<meta name="DC.Contributor" content="Nicole R. Sexton" />
<meta name="DC.Contributor" content="Everett Clinton Smith" />
<meta name="DC.Contributor" content="Susan R. Weiss" />
<meta name="DC.Contributor" content="Mark R. Denison" />
<meta name="article:published_time" content="2017-08-29" />
<meta name="article:section" content="New Results" />
<meta name="citation_title" content="Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity" />
<meta name="citation_abstract" lang="en" content="&lt;h3&gt;&lt;b&gt;ABSTRACT&lt;/b&gt;&lt;/h3&gt;
&lt;p&gt;Coronaviruses (CoV) are positive-sense RNA viruses that infect numerous mammalian and avian species and are capable of causing severe and lethal disease in humans. CoVs encode several innate immune antagonists that interact with the host innate immune response to facilitate efficient viral replication. CoV non-structural protein 14 (nsp14) encodes 39-to-59 exoribonuclease activity (ExoN), which performs a proofreading function and is required for high-fidelity replication. Outside of the order &lt;i&gt;Nidovirales&lt;/i&gt;, arenaviruses are the only RNA viruses that encode an ExoN, which functions to degrade dsRNA replication intermediates. In this study, we tested the hypothesis that CoV ExoN may also function to antagonize the innate immune response. We demonstrate that viruses lacking ExoN activity [ExoN(-)] are sensitive to cellular pretreatment with interferon beta (IFN-β) in a dose-dependent manner. In addition, ExoN(-) virus replication was attenuated in wild-type bone marrow-derived macrophages (BMMs) and partially restored in interferon alpha/beta receptor deficient (IFNAR-/-) BMMs. ExoN(-) virus replication did not result in IFN-β gene expression, and in the presence of an IFN-β-mediated antiviral state, ExoN(-) viral RNA levels were not substantially reduced relative to untreated. However, ExoN(-) virus generated from IFN-β pretreated cells had reduced specific infectivity and decreased relative fitness, suggesting that ExoN(-) virus generated during an antiviral state is less viable to establish a subsequent infection. Overall, our data suggest MHV ExoN activity is required for resistance to the innate immune response and antiviral mechanisms affecting the viral RNA sequence and/or an RNA modification act on viruses lacking ExoN activity.&lt;/p&gt;" />
<meta name="citation_journal_title" content="bioRxiv" />
<meta name="citation_publisher" content="Cold Spring Harbor Laboratory" />
<meta name="citation_publication_date" content="2017/01/01" />
<meta name="citation_mjid" content="biorxiv;182196v1" />
<meta name="citation_id" content="182196v1" />
<meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/182196v1" />
<meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/182196v1.abstract" />
<meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/182196v1.full" />
<meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196.full.pdf" />
<meta name="citation_doi" content="10.1101/182196" />
<meta name="citation_num_pages" content="37" />
<meta name="citation_article_type" content="Article" />
<meta name="citation_section" content="New Results" />
<meta name="citation_firstpage" content="182196" />
<meta name="citation_author" content="James Brett Case" />
<meta name="citation_author_institution" content="Departments of Pathology, Microbiology, and Immunology" />
<meta name="citation_author_institution" content="Elizabeth B. Lamb Center for Pediatric Research" />
<meta name="citation_author" content="Yize Li" />
<meta name="citation_author_institution" content="Department of Microbiology, Perelman School of Medicine" />
<meta name="citation_author" content="Ruth Elliott" />
<meta name="citation_author_institution" content="Department of Microbiology, Perelman School of Medicine" />
<meta name="citation_author" content="Xiaotao Lu" />
<meta name="citation_author_institution" content="Pediatrics" />
<meta name="citation_author_institution" content="Elizabeth B. Lamb Center for Pediatric Research" />
<meta name="citation_author" content="Kevin W. Graepel" />
<meta name="citation_author_institution" content="Departments of Pathology, Microbiology, and Immunology" />
<meta name="citation_author_institution" content="Elizabeth B. Lamb Center for Pediatric Research" />
<meta name="citation_author" content="Nicole R. Sexton" />
<meta name="citation_author_institution" content="Departments of Pathology, Microbiology, and Immunology" />
<meta name="citation_author_institution" content="Pediatrics" />
<meta name="citation_author_institution" content="Elizabeth B. Lamb Center for Pediatric Research" />
<meta name="citation_author" content="Everett Clinton Smith" />
<meta name="citation_author_institution" content="Department of Biology" />
<meta name="citation_author" content="Susan R. Weiss" />
<meta name="citation_author_institution" content="Department of Microbiology, Perelman School of Medicine" />
<meta name="citation_author" content="Mark R. Denison" />
<meta name="citation_author_institution" content="Departments of Pathology, Microbiology, and Immunology" />
<meta name="citation_author_institution" content="Pediatrics" />
<meta name="citation_author_institution" content="Elizabeth B. Lamb Center for Pediatric Research" />
<meta name="citation_author_email" content="mark.denison@vanderbilt.edu" />
<meta name="citation_reference" content="Roth-Cross JK, Martínez-Sobrido L, Scott EP, García-Sastre A, Weiss SR. 2007. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J Virol 81:7189–7199." />
<meta name="citation_reference" content="Frieman M, Heise M, Baric R. 2008. SARS coronavirus and innate immunity. Virus Res. 133:101–112." />
<meta name="citation_reference" content="Rose KM, Weiss SR. 2009. Murine Coronavirus Cell Type Dependent Interaction with the Type I Interferon Response. Viruses 1:689–712." />
<meta name="citation_reference" content="Schneider WM, Chevillotte MD, Rice CM. 2014. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32:513–545." />
<meta name="citation_reference" content="Kamitani W, Narayanan K, Huang C, Lokugamage K, Ikegami T, Ito N, Kubo H, Makino S. 2006. Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc. Natl. Acad. Sci. U.S.A. 103:12885–12890." />
<meta name="citation_reference" content="Zhang R, Li Y, Cowley TJ, Steinbrenner AD, Phillips JM, Yount BL, Baric RS, Weiss SR. 2015. The nsp1, nsp13, and M proteins contribute to the hepatotropism of murine coronavirus JHM.WU. J. Virol. 89:3598–3609." />
<meta name="citation_reference" content="Devaraj SG, Wang N, Chen Z, Chen Z, Tseng M, Barretto N, Lin R, Peters CJ, Tseng C-TK, Baker SC, Li K. 2007. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 282:32208–32221." />
<meta name="citation_reference" content="Barretto N, Jukneliene D, Ratia K, Chen Z, Mesecar AD, Baker SC. 2005. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J. Virol. 79:15189–15198." />
<meta name="citation_reference" content="Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, Guo D. 2009. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc Natl Acad Sci USA 106:3484–3489." />
<meta name="citation_reference" content="Decroly E, Imbert I, Coutard B, Bouvet M, Selisko B, Alvarez K, Gorbalenya AE, Snijder EJ, Canard B. 2008. Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity. J. Virol. 82:8071–8084." />
<meta name="citation_reference" content="Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, Gorbalenya AE, Silverman RH, Weiss SR. 2012. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 11:607–616." />
<meta name="citation_reference" content="Kindler E, Gil-Cruz C, Spanier J, Li Y, Wilhelm J, Rabouw HH, Züst R, Hwang M, V’kovski P, Stalder H, Marti S, Habjan M, Cervantes-Barragan L, Elliot R, Karl N, Gaughan C, van Kuppeveld FJM, Silverman RH, Keller M, Ludewig B, Bergmann CC, Ziebuhr J, Weiss SR, Kalinke U, Thiel V. 2017. Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication. PLoS Pathog. 13:e1006195." />
<meta name="citation_reference" content="Minskaia E, Hertzig T, Gorbalenya AE, Campanacci V, Cambillau C, Canard B, Ziebuhr J. 2006. Discovery of an RNA virus 3“-&gt;5” exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc Natl Acad Sci USA 103:5108–5113." />
<meta name="citation_reference" content="Case JB, Ashbrook AW, Dermody TS, Denison MR. 2016. Mutagenesis of SAdenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity. J. Virol. 90:7248–7256." />
<meta name="citation_reference" content="Eckerle LD, Lu X, Sperry SM, Choi L, Denison MR. 2007. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J Virol 81:12135–12144." />
<meta name="citation_reference" content="Smith EC, Blanc H, Vignuzzi M, Denison MR. 2013. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog 9:e1003565." />
<meta name="citation_reference" content="Graham RL, Becker MM, Eckerle LD, Bolles M, Denison MR, Baric RS. 2012. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat Med 18:1820–1826." />
<meta name="citation_reference" content="Qi X, Lan S, Wang W, Schelde LM, Dong H, Wallat GD, Ly H, Liang Y, Dong C. 2010. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779–783." />
<meta name="citation_reference" content="Hastie KM, Kimberlin CR, Zandonatti MA, MacRae IJ, Saphire EO. 2011. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3“ to 5” exonuclease activity essential for immune suppression. PNAS 108:2396–2401." />
<meta name="citation_reference" content="Russier M, Reynard S, Carnec X, Baize S. 2014. The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses. J. Virol. 88:13811–13820." />
<meta name="citation_reference" content="Becares M, Pascual-Iglesias A, Nogales A, Sola I, Enjuanes L, Zuñiga S. 2016. Mutagenesis of Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response. J. Virol. 90:5399–5414." />
<meta name="citation_reference" content="Rose KM, Elliott R, Martínez-Sobrido L, García-Sastre A, Weiss SR. 2010. Murine coronavirus delays expression of a subset of interferon-stimulated genes. J Virol 84:5656– 5669." />
<meta name="citation_reference" content="Ma Y, Wu L, Shaw N, Gao Y, Wang J, Sun Y, Lou Z, Yan L, Zhang R, Rao Z. 2015. Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex. PNAS 112:9436–9441." />
<meta name="citation_reference" content="Graepel K, Lu X, Case JB, Sexton NR, Smith EC, Denison MR. 2017. Proofreading-deficient coronaviruses adapt over long-term passage for increased fidelity and fitness without reversion of exoribonuclease-inactivating mutations. bioRxiv." />
<meta name="citation_reference" content="Zhao L, Rose KM, Elliott R, Van Rooijen N, Weiss SR. 2011. Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus. J. Virol. 85:10058–10068." />
<meta name="citation_reference" content="Zhao L, Birdwell LD, Wu A, Elliott R, Rose KM, Phillips JM, Li Y, Grinspan J, Silverman RH, Weiss SR. 2013. Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus. J. Virol. 87:8408–8418." />
<meta name="citation_reference" content="Tomaselli S, Galeano F, Locatelli F, Gallo A. 2015. ADARs and the Balance Game between Virus Infection and Innate Immune Cell Response. Curr Issues Mol Biol 17:37–51." />
<meta name="citation_reference" content="Neil S, Bieniasz P. 2009. Human immunodeficiency virus, restriction factors, and interferon. J. Interferon Cytokine Res. 29:569–580." />
<meta name="citation_reference" content="Gu J, Korteweg C. 2007. Pathology and pathogenesis of severe acute respiratory syndrome. Am. J. Pathol. 170:1136–1147." />
<meta name="citation_reference" content="Birdwell LD, Zalinger ZB, Li Y, Wright PW, Elliott R, Rose KM, Silverman RH, Weiss SR. 2016. Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon. J. Virol. 90:3160–3172." />
<meta name="citation_reference" content="Malathi K, Dong B, Gale M, Silverman RH. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448:816–819." />
<meta name="citation_reference" content="Bouvet M, Imbert I, Subissi L, Gluais L, Canard B, Decroly E. 2012. RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex. Proc. Natl. Acad. Sci. U.S.A. 109:9372–9377." />
<meta name="citation_reference" content="Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F. 2012. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13:223–228." />
<meta name="citation_reference" content="Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. 2011. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658–661." />
<meta name="citation_reference" content="Sanjuán R, Domingo-Calap P. 2016. Mechanisms of viral mutation. Cell. Mol. Life Sci. 73:4433–4448." />
<meta name="citation_reference" content="Chen W, Baric RS. 1996. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J. Virol. 70:3947–3960." />
<meta name="citation_reference" content="Yount B, Denison MR, Weiss SR, Baric RS. 2002. Systematic Assembly of a Full-Length Infectious cDNA of Mouse Hepatitis Virus Strain A59. J. Virol. 76:11065–11078." />
<meta name="citation_reference" content="Donaldson EF, Sims AC, Graham RL, Denison MR, Baric RS. 2007. Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis. J. Virol. 81:6356–6368." />
<meta name="twitter:title" content="Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity" />
<meta name="twitter:site" content="@biorxivpreprint" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="twitter:description" content="Coronaviruses (CoV) are positive-sense RNA viruses that infect numerous mammalian and avian species and are capable of causing severe and lethal disease in humans. CoVs encode several innate immune antagonists that interact with the host innate immune response to facilitate efficient viral replication. CoV non-structural protein 14 (nsp14) encodes 3'-to-5' exoribonuclease activity (ExoN), which performs a proofreading function and is required for high-fidelity replication. Outside of the order Nidovirales , arenaviruses are the only RNA viruses that encode an ExoN, which functions to degrade dsRNA replication intermediates. In this study, we tested the hypothesis that CoV ExoN may also function to antagonize the innate immune response. We demonstrate that viruses lacking ExoN activity [ExoN(-)] are sensitive to cellular pretreatment with interferon beta (IFN-β) in a dose-dependent manner. In addition, ExoN(-) virus replication was attenuated in wild-type bone marrow-derived macrophages (BMMs) and partially restored in interferon alpha/beta receptor deficient (IFNAR-/-) BMMs. ExoN(-) virus replication did not result in IFN-β gene expression, and in the presence of an IFN-β-mediated antiviral state, ExoN(-) viral RNA levels were not substantially reduced relative to untreated. However, ExoN(-) virus generated from IFN-β pretreated cells had reduced specific infectivity and decreased relative fitness, suggesting that ExoN(-) virus generated during an antiviral state is less viable to establish a subsequent infection. Overall, our data suggest MHV ExoN activity is required for resistance to the innate immune response and antiviral mechanisms affecting the viral RNA sequence and/or an RNA modification act on viruses lacking ExoN activity." />
<meta name="og-title" property="og:title" content="Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity" />
<meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/182196v1" />
<meta name="og-site-name" property="og:site_name" content="bioRxiv" />
<meta name="og-description" property="og:description" content="Coronaviruses (CoV) are positive-sense RNA viruses that infect numerous mammalian and avian species and are capable of causing severe and lethal disease in humans. CoVs encode several innate immune antagonists that interact with the host innate immune response to facilitate efficient viral replication. CoV non-structural protein 14 (nsp14) encodes 3'-to-5' exoribonuclease activity (ExoN), which performs a proofreading function and is required for high-fidelity replication. Outside of the order Nidovirales , arenaviruses are the only RNA viruses that encode an ExoN, which functions to degrade dsRNA replication intermediates. In this study, we tested the hypothesis that CoV ExoN may also function to antagonize the innate immune response. We demonstrate that viruses lacking ExoN activity [ExoN(-)] are sensitive to cellular pretreatment with interferon beta (IFN-β) in a dose-dependent manner. In addition, ExoN(-) virus replication was attenuated in wild-type bone marrow-derived macrophages (BMMs) and partially restored in interferon alpha/beta receptor deficient (IFNAR-/-) BMMs. ExoN(-) virus replication did not result in IFN-β gene expression, and in the presence of an IFN-β-mediated antiviral state, ExoN(-) viral RNA levels were not substantially reduced relative to untreated. However, ExoN(-) virus generated from IFN-β pretreated cells had reduced specific infectivity and decreased relative fitness, suggesting that ExoN(-) virus generated during an antiviral state is less viable to establish a subsequent infection. Overall, our data suggest MHV ExoN activity is required for resistance to the innate immune response and antiviral mechanisms affecting the viral RNA sequence and/or an RNA modification act on viruses lacking ExoN activity." />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="citation_date" content="2017-08-29" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/182196v1.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/182196v1.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/182196v1.ppt" />
<meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.biorxiv.org/content/10.1101/182196v1" />
<link rel="shortlink" href="https://www.biorxiv.org/node/55028" />
    <title>Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity | bioRxiv</title>  
    <link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__jMRAK66KMC1e4TQlwUNn3KiWVDC5AjueUAYEm1xBY_U__KSUjdT4jdcJ4qJz6fKY1K9WkYh1a5EcaWZxt_-zbTis__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/all/modules/highwire/highwire/highwire.style.highwire.css?q8qadd" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__qlYh2rDEXmsOlJKnxoaEiN2PoZU7YzDXSSTk6K1VAQE__XkaAZGAgxyDmOmv0mrGL0sA-jzEgAbgA12amvVPlIf0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__GFpBMW7A95ZNl4oKhiI_0u7WD_8tFHiDfbKIVNkYgis__uourhtZYS_vAk2DtacwQIGmpE376HP4afgwMlmHZpq0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__B6tGdsQSt1vT8d8j-19-oS4FKJe83RrSNBkjPs9jfos__6VkE5WcQmmQpSVTQx-xS2-zn_nlwFlDm-EN1HLJNjrA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__78WRxe8YsWkYp6RcQ_VwTjFG__x9mi_NTPqoxAwFUsA__F3sVKlGyHKCaAPI_WdiHD7l_-05B6b9bLdUwzi1me90__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__dAeSAHswzRXxn-2n4D6zNPmcZDmwaqqLzE-2ab_8jKw__f_9pwrTE8mmshoJRfurwkQ36QonD_Jiwbop2sscnkrE__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom.css" media="all" />
    <script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/all/libraries/modernizr/modernizr.min.js?q8qadd"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__yOhrJUBmMpN-jsuQlJYmS8ovkQU6I6KInr295HrSTb0__c--zHhbuOWmkdWkJYXiNWDmkpDRPesmbBjGlQcyqBOY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js___KyvuEvfmewWxdOLBXTYsSUo8Pfm_DijV6fWtGvSL_k__HSKkTgIr7nDcdvQYewipf6v4ak6ZLUOQkwPj44wKouA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__OGPr3wJNGw2BAY3Tj6TjIBwKmjQh5i-7muOaPrr0MFA__fCWiU_pDm6xztXUSccH7zrf5422-kgOkuLdWyafrH_0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__hqoKSXYZqkcZkXP--ltzsy0Y3txW5TJBw6HT1khr30Y__6_HqNYoBVMxlkWZwdscqCLCtCxpOhl9_rIOpTDdaI0k__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__lrItkPGmrIuH-E_sdUWEK2i9eTqLar16BAHVxNTWqrc__FhtnljBrjuzYWWrT_f4OYV4jtMBituhMpusb3h0m0rY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-45638026-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__1PtAOZ8x7l6QAi8D7X6Kj_Y7HcUOFzvWRvvYHUcCT98__U8IB92u_CnnGwJ-X_xaUa9lzsC8OzUfN0WkK2JQfirg__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"lLUfCEiZlex2qpo0quEhZ3Anx9o-6CEuel90RKhKObE","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"misc\/ui\/jquery.ui.button.css":1,"misc\/ui\/jquery.ui.resizable.css":1,"misc\/ui\/jquery.ui.dialog.css":1,"misc\/ui\/jquery.ui.tooltip.css":1,"modules\/comment\/comment.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"sites\/all\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_draw\/css\/highwire-draw.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_folders\/highwire_folders.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/css\/highwire-responsive.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_saved_searches\/highwire_saved_searches.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/highwire_user.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"modules\/forum\/forum.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.highwire.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/nlm-elements.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/default\/modules\/biorxiv\/css\/biorxiv.css":1,"public:\/\/ctools\/css\/263bfdb18936424f0ade19d6bd885f37.css":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/css\/panels_ajax_tab.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.markup.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/layouts\/highwire_2col_stacked\/highwire-2col-stacked.css":1,"sites\/all\/modules\/contrib\/forward\/forward.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_share_link.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_copy_permalink.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/flexible\/flexible.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_collection\/css\/highwire_subject_collection.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire.highwire-list-expand.css":1,"public:\/\/ctools\/css\/bab59090150caf0c64e27afa1b36eef1.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/css\/eu_cookie_compliance.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons-glyphs.css":1,"0":1,"sites\/all\/themes\/highwire\/jcore_1\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome-ie7.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-reset.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-mobile.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-alpha.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/formalize.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-text.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-branding.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-menu.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-forms.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire-forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/mobile-reset.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/global.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/jquery-ui-elements.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/text.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/colors.css.less":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-narrow.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/narrow\/jcore-default-narrow-30.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-wide.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/wide\/jcore-default-wide-30.css":1,"sites\/default\/modules\/jnl_biorxiv_styles\/css\/biorxiv-styles.css.less":1,"https:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.css":1},"js":{"sites\/all\/libraries\/enquire.js\/enquire.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js":1,"sites\/all\/libraries\/lazysizes\/lazysizes.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_figures.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_google_scholar_sprinkle.js":1,"http:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/eu_cookie_compliance.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/adv-search-collection-toggle.js":1,"sites\/all\/libraries\/modernizr\/modernizr.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.button.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.mouse.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.draggable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.resizable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.dialog.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.tooltip.min.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/jquery.cookie-1.4.1.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.equal-heights.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.panels-ajax-tab.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/biorxiv-scripts.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"https:\/\/scholar.google.com\/scholar_js\/casa.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_log\/highwire_log.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_nps_survey\/js\/nps_survey.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/js\/highwire_user_meta.js":1,"sites\/all\/modules\/contrib\/panels\/js\/panels.js":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.article-citation-author-tooltip.js":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/js\/panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js":1,"sites\/default\/modules\/contrib\/disqus\/disqus.js":1,"misc\/textarea.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_share_dialog.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/clipboard.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_clipboard.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_citation\/plugins\/content_types\/js\/highwire_citation_export.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/minipanel_dialog_link.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/twitter_button.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/facebook_like.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/google_plus_one.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.highwire-list-expand.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"sites\/all\/themes\/highwire\/jcore_1\/js\/theme-scripts.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/jquery.formalize.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-mediaqueries.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-equalheights.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/js\/highwire-mediaqueries.js":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"55028","apath":"\/biorxiv\/early\/2017\/08\/29\/182196.atom","pisa":"biorxiv;182196v1","processed":["highwire_math"],"markup":[{"requested":"full-text","variant":"full-text","view":"full","pisa":"biorxiv;182196v1"}],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"biorxivstage","url":"https:\/\/www.biorxiv.org\/content\/10.1101\/182196v1","title":"Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity","identifier":"node\/55028"},"panels_ajax_pane":{"new-41":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u00220R\\\\\\\/bAKhTODTWwC5XZYiomieFVHBF48wkXxtM1yV1C+WRpfZ6kT3GAXj1+zZ+vYmLclQzY1oBaT23nZCkHdzSorRz48aiTHjQ84iNVRm+BIdKlZxFkKwHlC9gBqSpLptiYN+TvU5BVzSp++Df\\\\\\\/UmblOFrTv\\\\\\\/FQNVDkZIcoYcRGQbCrTc0iiX0869SFzXF0D38aRReEpd1+AIlefWJ3nHkVwqrsR+OtQFu\\\\\\\/CGs8\\\\\\\/a9wcDKN9VI\\\\\\\/IBH3RymOgB8AiRtk7PX6MlQnjDEXzfvc4PCR6kt5xXWznE6uViQdAAZy\\\\\\\/ITwAQ4LFmA0yKnVCMa4NyJ5u+jYrCeyHJf3CN1aF\\\\\\\/c2JDQivqZAqMIVt8KcXRHsDb\\\\\\\/3g1Mar0\\\\\\\/oEUrLVMeFqE8gLuANgB\\\\\\\/qCviWd4abvKRph\\\\\\\/8cuKL5z2+25KNZskeHcsvdvYze8khcinBjjloyk16ikbIptN0sUgM5NWYpV3oE3z\\\\\\\/eg7IUojnCwPVSWagou\\\\\\\/m4fsnYG62Ew1rwi+iIPHJC6X7yIbIzDkn5L7175RHKE4hJ4kjyuNV6Zi9VMmMq8aiZu1tY+B6KVRnI+Rroe3h9KHZc5jAp2865iSWJoKwI3HcEcgFf0L1698ESFNJmHX0SGFhVOiauQ1dxWGIeGv+b40jnXvqlzp4filvOUoDQbSYvvw3mQyjEqXnobsxbshf43Bq88WAt6vEkVD1c2zxf\\\\\\\/z8hrOwOX1k7vIfM+GKt+pHt8\\\\\\\/n12exOwZ\\\\\\\/7WVzUmQHxPp5JY70ClnpuZn3NPT4n3h4Ozqcu8LP2stwX\\\\\\\/5CTYnZnoVWhmYLMo0JIAn1m21y\\\\\\\/IDpuzyuyQ4Can9dfjeqnNm\\\\\\\/fuzeJKN5m65nqwhvldT1f1CDU3SxE1lMv60ZizoDNmy3Z6LTx6eBMafWqbzpnmOB+ngVafgKb4in0IJLPgr\\\\\\\/YTbkoqo+kk6fYID7wj+3jTw75JONsXysgZpyehgmH9zuBtM6Heh5yR1CqJC5OCnSqyJ0N7wBJLBTzFjRab82COcADK32gJLaTqIVOhEJFlz9FGSPUn6S7OVYxvn5WD5M806by5oqlkazVcLEa6memcuW7LhGFvSbG+pYCww9ECTjbZ7eqe5jNqQZSB8\\\\\\\/6iu6cGIAekV5afYFizmFVdfdu2vMBMNgYWJHH3d1+UVsuoR3yxR8PXvPb\\\\\\\/NdmzfImEi1ynfBhe2ZPOqOFiSeoaib41D0BAEqaqIBD7MWMbNOvrwfEqRKVsEdJV+ElqoTTpuZtaA1FispBuZpo8KHvNMxc+X4Bgw1CIFYArmz7ar4QIDgkq0yexgMJGaDNn3LVRMEzruANZQJJshsp+cMTDg=\\\u0022,\\\u0022iv\\\u0022:\\\u0022w6KjpPKDabu+RajOG1bMCQ==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u00224e52a72eddc24ad490384d1d1b14e6f9921ad012554598cc6fe83678338dadb2\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/182196v1.full":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.biorxiv.org\/sites\/default\/files\/bioRxiv_article.jpg"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"biorxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-55028 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results">
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-M677548" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script type="text/javascript">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548');</script>
<!-- End Google Tag Manager -->
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
        <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
    
  <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
    <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="branding-data clearfix">
            <div class="logo-img">
        <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0"><img alt="bioRxiv" src="https://www.biorxiv.org/sites/default/files/bioRxiv_article.jpg" /></a>      </div>
                </div>
          </div>
</div><div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">Home</a></li>
<li class="leaf" role="menuitem"><a href="/about-biorxiv" class="" data-icon-position="" data-hide-link-title="0">About</a></li>
<li class="leaf" role="menuitem"><a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">Submit</a></li>
<li class="last leaf" role="menuitem"><a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">ALERTS / RSS</a></li>
</ul></nav>    </div>
  </div>
</div><div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/182196v1.full" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search" type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--2" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-riKHb7CO6NIDZ6Rt05Q7ONK2jk5URX6uGpMsA7PlKhI" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 advanced-search-link" >
  
      
  
  <div class="pane-content">
    <a href="/search">Advanced Search</a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="55028" id="node55028" data-pisa="biorxiv;182196v1" data-pisa-master="biorxiv;182196" data-apath="/biorxiv/early/2017/08/29/182196.atom" data-hw-author-tooltip-instance="highwire_author_tooltip"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-top clearfix has-author-tooltip" >

      <span class="biorxiv-article-type">
        New Results    </span>
  
        <h1 class="highwire-cite-title" id="page-title">Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity</h1>  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">James Brett</span> <span class="nlm-surname">Case</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Yize</span> <span class="nlm-surname">Li</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Ruth</span> <span class="nlm-surname">Elliott</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Xiaotao</span> <span class="nlm-surname">Lu</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Kevin W.</span> <span class="nlm-surname">Graepel</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Nicole R.</span> <span class="nlm-surname">Sexton</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Everett Clinton</span> <span class="nlm-surname">Smith</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Susan R.</span> <span class="nlm-surname">Weiss</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">Mark R.</span> <span class="nlm-surname">Denison</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">doi:</span> https://doi.org/10.1101/182196 </span></div>
  
  
  </div>
<div id="hw-article-author-popups-node55028" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">James Brett Case </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>a</span><span class='nlm-institution'>Departments of Pathology, Microbiology, and Immunology</span>, Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div><div class='author-affiliation'><span class='nlm-sup'>c</span><span class='nlm-institution'>Elizabeth B. Lamb Center for Pediatric Research</span>,Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=James%2BBrett%2BCase%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Case%20JB&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AJames%2BBrett%2BCase%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">Yize Li </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>d</span><span class='nlm-institution'>Department of Microbiology, Perelman School of Medicine</span>, University of Pennsylvania, Philadelphia, Pennsylvania, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Yize%2BLi%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Li%20Y&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AYize%2BLi%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Ruth Elliott </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>d</span><span class='nlm-institution'>Department of Microbiology, Perelman School of Medicine</span>, University of Pennsylvania, Philadelphia, Pennsylvania, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Ruth%2BElliott%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Elliott%20R&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ARuth%2BElliott%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-3"><div class="author-tooltip-name">Xiaotao Lu </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>b</span><span class='nlm-institution'>Pediatrics</span>, Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div><div class='author-affiliation'><span class='nlm-sup'>c</span><span class='nlm-institution'>Elizabeth B. Lamb Center for Pediatric Research</span>,Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Xiaotao%2BLu%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Lu%20X&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AXiaotao%2BLu%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-4"><div class="author-tooltip-name">Kevin W. Graepel </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>a</span><span class='nlm-institution'>Departments of Pathology, Microbiology, and Immunology</span>, Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div><div class='author-affiliation'><span class='nlm-sup'>c</span><span class='nlm-institution'>Elizabeth B. Lamb Center for Pediatric Research</span>,Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Kevin%2BW.%2BGraepel%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Graepel%20KW&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AKevin%2BW.%2BGraepel%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-5"><div class="author-tooltip-name">Nicole R. Sexton </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>a</span><span class='nlm-institution'>Departments of Pathology, Microbiology, and Immunology</span>, Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div><div class='author-affiliation'><span class='nlm-sup'>b</span><span class='nlm-institution'>Pediatrics</span>, Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div><div class='author-affiliation'><span class='nlm-sup'>c</span><span class='nlm-institution'>Elizabeth B. Lamb Center for Pediatric Research</span>,Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Nicole%2BR.%2BSexton%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Sexton%20NR&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ANicole%2BR.%2BSexton%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-6"><div class="author-tooltip-name">Everett Clinton Smith </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>e</span><span class='nlm-institution'>Department of Biology</span>, The University of the South, Sewanee, Tennessee, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Everett%2BClinton%2BSmith%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Smith%20EC&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AEverett%2BClinton%2BSmith%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-7"><div class="author-tooltip-name">Susan R. Weiss </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>d</span><span class='nlm-institution'>Department of Microbiology, Perelman School of Medicine</span>, University of Pennsylvania, Philadelphia, Pennsylvania, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Susan%2BR.%2BWeiss%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Weiss%20SR&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ASusan%2BR.%2BWeiss%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-8"><div class="author-tooltip-name">Mark R. Denison </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>a</span><span class='nlm-institution'>Departments of Pathology, Microbiology, and Immunology</span>, Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div><div class='author-affiliation'><span class='nlm-sup'>b</span><span class='nlm-institution'>Pediatrics</span>, Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div><div class='author-affiliation'><span class='nlm-sup'>c</span><span class='nlm-institution'>Elizabeth B. Lamb Center for Pediatric Research</span>,Vanderbilt University Medical Center, Nashville, Tennessee, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Mark%2BR.%2BDenison%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Denison%20MR&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3AMark%2BR.%2BDenison%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:mark.denison@vanderbilt.edu" class="" data-icon-position="" data-hide-link-title="0">mark.denison@vanderbilt.edu</a></span></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/10.1101/182196v1" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:55028" data-trigger="" data-url-enabled="1">Abstract</a><a href="/panels_ajax_tab/biorxiv_tab_art/node:55028/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/182196v1.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:55028" data-trigger="full-text" data-url-enabled="1">Full Text</a><a href="/panels_ajax_tab/article_tab_full_text/node:55028/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/182196v1.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:55028" data-trigger="article-info" data-url-enabled="1">Info/History</a><a href="/panels_ajax_tab/biorxiv_tab_info/node:55028/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/182196v1.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:55028" data-trigger="article-metrics" data-url-enabled="1">Metrics</a><a href="/panels_ajax_tab/article_tab_metrics/node:55028/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/10.1101/182196v1.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:55028" data-trigger="full.pdf+html" data-url-enabled="1"><i class="icon-file-alt"></i> Preview PDF</a><a href="/panels_ajax_tab/biorxiv_tab_pdf/node:55028/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="article_tab_full_text" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-article_tab_full_text"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" id="content-block-markup" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class=""><strong>ABSTRACT</strong></h2><p id="p-2">Coronaviruses (CoV) are positive-sense RNA viruses that infect numerous mammalian and avian species and are capable of causing severe and lethal disease in humans. CoVs encode several innate immune antagonists that interact with the host innate immune response to facilitate efficient viral replication. CoV non-structural protein 14 (nsp14) encodes 3'-to-5' exoribonuclease activity (ExoN), which performs a proofreading function and is required for high-fidelity replication. Outside of the order <em>Nidovirales</em>, arenaviruses are the only RNA viruses that encode an ExoN, which functions to degrade dsRNA replication intermediates. In this study, we tested the hypothesis that CoV ExoN may also function to antagonize the innate immune response. We demonstrate that viruses lacking ExoN activity [ExoN(-)] are sensitive to cellular pretreatment with interferon beta (IFN-β) in a dose-dependent manner. In addition, ExoN(-) virus replication was attenuated in wild-type bone marrow-derived macrophages (BMMs) and partially restored in interferon alpha/beta receptor deficient (IFNAR-/-) BMMs. ExoN(-) virus replication did not result in IFN-β gene expression, and in the presence of an IFN-β-mediated antiviral state, ExoN(-) viral RNA levels were not substantially reduced relative to untreated. However, ExoN(-) virus generated from IFN-β pretreated cells had reduced specific infectivity and decreased relative fitness, suggesting that ExoN(-) virus generated during an antiviral state is less viable to establish a subsequent infection. Overall, our data suggest MHV ExoN activity is required for resistance to the innate immune response and antiviral mechanisms affecting the viral RNA sequence and/or an RNA modification act on viruses lacking ExoN activity.</p></div><div class="section" id="sec-1"><h2 class="">IMPORTANCE</h2><p id="p-3">CoVs encode multiple antagonists that prevent or disrupt an efficient innate response. Additionally, no specific antiviral therapies or vaccines currently exist for human CoV infections. Therefore, the study of CoV innate immune antagonists is essential for understanding how CoVs overcome host defenses and to maximize potential therapeutic interventions. Here, we sought to determine the contributions of nsp14 ExoN activity in the induction of and resistance to the innate immune response. We show that viruses lacking nsp14-ExoN activity are more sensitive to restriction by exogenous IFN-β and that viruses produced in the presence of an antiviral state are less capable of establishing a subsequent viral infection. Our results support the hypothesis that MHV ExoN activity is required for resistance to the innate immune response.</p></div><div class="section" id="sec-2"><h2 class="">INTRODUCTION</h2><p id="p-4">The innate immune response within a mammalian cell is the first line of defense against an invading pathogen. However, as obligate intracellular parasites, viruses have evolved numerous mechanisms to prevent and antagonize innate detection by host cells. Coronaviruses (CoVs), which are the largest known positive-sense, single-stranded RNA viruses, encode several type I interferon (IFN) antagonists. Many of these antagonists prevent the induction of IFN, while others mediate resistance to the effects of IFN (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>-<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>). Upon secretion from a cell, IFNs bind to cell surface-expressed IFN-α/β receptors (IFNARs) in an autocrine and paracrine manner. Subsequently, an IFN signaling cascade utilizing the Janus kinase and signal transducer and activator of transcription pathway leads to the induction and expression of hundreds of interferon stimulated genes (ISGs) that act to limit or prevent viral replication and spread (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>). However, during CoV infection, nonstructural protein (nsp) 1 antagonizes the innate immune response by degrading host mRNAs and suppressing IFN beta (IFN-β) expression (<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>, <a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>). The nsp3 of severe acute respiratory syndrome coronavirus (SARS-CoV) prevents IRF3 phosphorylation and NF-ϰ B signaling (<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>). In addition, SARS-CoV nsp3 encodes deubiquitinating and deISGylating activities (<a id="xref-ref-3-2" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>). CoV viral RNA evades innate detection by pattern recognition receptors (PRRs) such as MDA5, and antiviral effectors, such as IFIT1, through formation of a 5' cap-1 structure by encoding N7-methyltransferase and 2'O-methyltransferase activities within nsp14 and nsp16, respectively (<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>, <a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>). Murine hepatitis virus (MHV) and Middle East respiratory syndrome coronavirus (MERS-CoV) also encode 2'-5' phosphodiesterases that degrade 2'-5' oligoadenylates, which are key signaling molecules generated by oligoadenylate synthetase (OAS) in response to innate detection of dsRNA that subsequently activate RNase L (<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>). Most recently, a CoV nsp15 endonuclease activity (EndoU) mutant virus was shown to have increased dsRNA levels, suggesting that nsp15 EndoU reduces dsRNA levels during infection (<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>).</p><p id="p-5">CoV nsp14 encodes 3'-to-5' exoribonuclease (ExoN) and N7-methyltransferase (N7-MTase) activities (<a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9</a>, <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>). CoV nsp14 N7-MTase activity is essential for efficient translation of the viral genome and preventing innate detection (<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>). In addition, initial biochemical studies of nsp14 ExoN activity demonstrated that ExoN has a preference for dsRNA and the capacity to excise 3' end misincorporated nucleotides (<a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">13</a>). Moreover, nsp14 ExoN activity is required for high-fidelity replication. The CoV nsp14 ExoN is a member of the DE-D-Dh superfamily of DNA and RNA exonucleases, so named for the three motifs of four active site residues (<a id="xref-ref-13-3" class="xref-bibr" href="#ref-13">13</a>). <em>Betacoronaviruses</em> SARS-CoV and MHV expressing engineered, ExoN-inactivating substitutions at active site residues in Motif I (DE → AA) [ExoN(-)] demonstrate increased mutation frequencies and are profoundly sensitive to inhibition by RNA mutagens (<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>). Additionally, SARS-CoV ExoN(-) virus is attenuated <em>in vivo</em> (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>). Interestingly, outside of the order <em>Nidovirales</em>, the only other known RNA virus-encoded 3'-to-5' exoribonucleases are found in the <em>Arenaviridae</em> family of viruses. Lassa fever virus nucleoprotein ExoN is not thought to participate in fidelity regulation, but rather it participates in immune evasion by degrading dsRNA and thereby prevents antigen-presenting cell-mediated NK cell activation (<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>-<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>). Recently, in the <em>Alphacoronavirus</em> transmissible gastroenteritis virus (TGEV), a mutation in the nsp14 ExoN zinc finger was shown to generate lower levels of dsRNA compared to wild-type (WT) TGEV. However, in that study viruses with mutations in ExoN active site motifs were non-viable and therefore, could not be directly tested for effects on innate immunity (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>).</p><p id="p-6">Here, we demonstrate that viruses lacking ExoN activity were sensitive to the effects of IFN pretreatment. In addition, for viruses lacking ExoN activity, replication was restricted in wild-type bone marrow derived macrophages (B6, BMMs) but restored in interferon alpha/beta receptor deficient (IFNAR-/-) BMMs. Despite an increased sensitivity to the effects of IFN treatment, MHV ExoN mutants failed to induce detectable IFN-β gene expression or RNase L-mediated ribosomal RNA (rRNA) degradation and only a limited decrease in viral RNA accumulation was observed. Finally, ExoN(-) virus replicated in the presence of an IFN-βmediated antiviral state had both a decreased specific infectivity and decreased relative fitness compared to untreated ExoN(-) virus. Thus, nsp14 ExoN appears to block or correct the restriction of MHV infection by an IFN-mediated mechanism that may involve damaging nascent viral RNA and affecting subsequent infectivity.</p></div><div class="section" id="sec-3"><h2 class="">RESULTS</h2><div id="sec-4" class="subsection"><h3>Viruses lacking ExoN activity are sensitive to the effects of IFN-β</h3><p id="p-7">Binding of type I interferon to the IFNAR receptor on the cell surface leads to a Jak/STAT signaling cascade that ultimately results in the up-regulation and expression of hundreds of antiviral ISGs (<a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>). In addition, WT-MHV replication has been shown to be relatively resistant to the effects of IFN (<a id="xref-ref-1-2" class="xref-bibr" href="#ref-1">1</a>, <a id="xref-ref-3-3" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>). To determine whether the ExoN activity of MHV nsp14 was required for resistance to IFN, we pretreated murine delayed brain tumor (DBT) cells with increasing concentrations of mouse IFN-β for 18 h prior to infecting with WT-MHV or ExoN(-) virus at a multiplicity of infection (MOI) of 1 plaque-forming unit (PFU) per cell (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Fig. 1A</a>). In response to IFN-β pretreatment, WT-MHV viral titer decreased by approximately 1 log<sub>10</sub> as previously reported (<a id="xref-ref-1-3" class="xref-bibr" href="#ref-1">1</a>). In contrast, ExoN(-) viral titer demonstrated a dose-dependent decrease and resulted in an approximately 3 log<sub>10</sub> decrease in viral titer relative to untreated ExoN(-) viral titers. The ExoN activity of nsp14 is conferred by active site residues present in 3 different motifs within the ExoN domain (<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>). Therefore, to determine whether the observed sensitivity to IFN-β pretreatment for ExoN(-) virus in <a id="xref-fig-1-2" class="xref-fig" href="#F1">Fig. 1A</a> was due specifically to the absence of ExoN activity in nsp14, we engineered and recovered a virus encoding only an aspartic acid to alanine substitution in Motif III [ExoN3 (-)]. Previously, we have demonstrated that viruses lacking ExoN activity have decreased replication fidelity and are sensitive to the RNA mutagen 5-fluorouracil (5-FU) (<a id="xref-ref-16-2" class="xref-bibr" href="#ref-16">16</a>). Hence, 5-FU sensitivity is an <em>in vitro</em> indicator of ExoN activity. Therefore, first, we tested whether ExoN3 (-) and ExoN(-) demonstrated similar sensitivity to 5-FU to ensure that the ExoN activity of ExoN3 (-) virus had been ablated. Similar to ExoN(-), ExoN3 (-) viral replication in cells treated with increasing concentrations of 5-FU demonstrated a dose-dependent decrease in viral titer relative to vehicle treated cells (<a id="xref-fig-1-3" class="xref-fig" href="#F1">Fig. 1B</a>). Further, ExoN(-) and ExoN3(-) displayed similar sensitivities to pre-treatment with 100 or 500 U/mL IFN-β following infection at an MOI of 1 PFU/cell (<a id="xref-fig-1-4" class="xref-fig" href="#F1">Fig. 1C</a>). Thus, these data suggest nsp14 ExoN activity is required for resistance to the effects of IFN-β pretreatment and subsequent up-regulation and expression of ISGs.</p><div id="F1" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F1.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Viruses lacking ExoN activity are sensitive to IFN-&#x3B2; pretreatment. (A) DBT cells were pretreated with the indicated concentrations of mouse IFN-&#x3B2; for 18 h and then infected with WTMHV or ExoN(-) virus (A) or WT, ExoN(-), or ExoN3 (-) virus (C) at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected and the viral titers present determined by plaque assay. (B) DBT cells were pretreated with the indicated concentrations of 5-FU for 30 min. Following pretreatment, cells were infected with WT, ExoN(-), or ExoN3 (-) virus at an MOI of 1 PFU/cell for 45 min., inocula were removed, and fresh medium containing vehicle or the appropriate concentration of 5-FU were added. Cell culture supernatants were harvested 12 h post-infection and viral titers were determined by plaque assay. For each panel, the change in viral titer was calculated by dividing viral titers following the indicated treatment by the untreated controls and error bars indicate SEM (n = 4). Statistical significance compared to WT-MHV is denoted and was determined by Student's t &#x2013; test. *, P &lt; 0.05, **P &lt; 0.01, *** P &lt; 0.001." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-998985183" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;Viruses lacking ExoN activity are sensitive to IFN-&#x3B2; pretreatment. (A) DBT cells were pretreated with the indicated concentrations of mouse IFN-&#x3B2; for 18 h and then infected with WTMHV or ExoN(-) virus (A) or WT, ExoN(-), or ExoN3 (-) virus (C) at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected and the viral titers present determined by plaque assay. (B) DBT cells were pretreated with the indicated concentrations of 5-FU for 30 min. Following pretreatment, cells were infected with WT, ExoN(-), or ExoN3 (-) virus at an MOI of 1 PFU/cell for 45 min., inocula were removed, and fresh medium containing vehicle or the appropriate concentration of 5-FU were added. Cell culture supernatants were harvested 12 h post-infection and viral titers were determined by plaque assay. For each panel, the change in viral titer was calculated by dividing viral titers following the indicated treatment by the untreated controls and error bars indicate SEM (n = 4). Statistical significance compared to WT-MHV is denoted and was determined by Student's &lt;em&gt;t&lt;/em&gt; &#x2013; test. *, &lt;em&gt;P&lt;/em&gt; &lt; 0.05, **&lt;em&gt;P&lt;/em&gt; &lt; 0.01, *** &lt;em&gt;P&lt;/em&gt; &lt; 0.001.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F1.medium.gif" width="147" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="FIG 1." src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F1.medium.gif" width="147" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download FIG 1." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml"><span class="fig-label">FIG 1.</span> <p id="p-8" class="first-child">Viruses lacking ExoN activity are sensitive to IFN-β pretreatment. (A) DBT cells were pretreated with the indicated concentrations of mouse IFN-β for 18 h and then infected with WTMHV or ExoN(-) virus (A) or WT, ExoN(-), or ExoN3 (-) virus (C) at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected and the viral titers present determined by plaque assay. (B) DBT cells were pretreated with the indicated concentrations of 5-FU for 30 min. Following pretreatment, cells were infected with WT, ExoN(-), or ExoN3 (-) virus at an MOI of 1 PFU/cell for 45 min., inocula were removed, and fresh medium containing vehicle or the appropriate concentration of 5-FU were added. Cell culture supernatants were harvested 12 h post-infection and viral titers were determined by plaque assay. For each panel, the change in viral titer was calculated by dividing viral titers following the indicated treatment by the untreated controls and error bars indicate SEM (n = 4). Statistical significance compared to WT-MHV is denoted and was determined by Student's <em>t</em> – test. *, <em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, *** <em>P</em> &lt; 0.001.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-5" class="subsection"><h3>Increased replication capacity does not confer resistance to the effects of IFN-β pretreatment for viruses lacking ExoN activity</h3><p id="p-9">ExoN(-) virus demonstrates an approximately 2 h delay in exponential replication and a 1 log<sub>10</sub> decrease in peak titer relative to WT-MHV (<a id="xref-ref-15-2" class="xref-bibr" href="#ref-15">15</a>). Therefore, we tested whether the IFN sensitivity phenotype observed for ExoN(-) and ExoN3 (-) viruses is due to the decreased replication capacity of these viruses. To do so, we utilized an ExoN(-) virus developed by our lab that has been blindly passaged in DBT cells for 250 passages [ExoN(-) P250] (<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>). The replication capacity of the resulting ExoN(-) P250 virus exceeds that of WT-MHV (<a id="xref-fig-2-1" class="xref-fig" href="#F2">Fig. 2A</a>). However, despite increased replication capacity, ExoN(-) P250 demonstrated similar sensitivity to IFN-β pretreatment as ExoN(-) virus (<a id="xref-fig-2-2" class="xref-fig" href="#F2">Fig. 2A</a> and B). Hence, the IFN-β sensitivity phenotype of viruses lacking ExoN activity is not dependent on viral replication capacity but instead, is directly associated with a specific function of nsp14 ExoN that is required for efficient replication in the presence of an IFN-β-mediated antiviral state.</p><div id="F2" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F2.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Increased replication capacity does not restore virus resistance to IFN-&#x3B2;. DBT cells were pretreated with the indicated concentrations of mouse IFN-&#x3B2; for 18 h and then infected with WT, ExoN(-), or ExoN(-) P250 virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected and the viral titers present determined by plaque assay. Raw viral titers (A) or the change in viral titers relative to untreated controls (B) are reported. Error bars indicate SEM (n = 4). Statistical significance compared to WT-MHV is denoted and was determined by Student's t &#x2013; test. *, P &lt; 0.05, **P &lt; 0.01, *** P &lt; 0.001." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-998985183" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;Increased replication capacity does not restore virus resistance to IFN-&#x3B2;. DBT cells were pretreated with the indicated concentrations of mouse IFN-&#x3B2; for 18 h and then infected with WT, ExoN(-), or ExoN(-) P250 virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected and the viral titers present determined by plaque assay. Raw viral titers (A) or the change in viral titers relative to untreated controls (B) are reported. Error bars indicate SEM (n = 4). Statistical significance compared to WT-MHV is denoted and was determined by Student's &lt;em&gt;t&lt;/em&gt; &#x2013; test. *, &lt;em&gt;P&lt;/em&gt; &lt; 0.05, **&lt;em&gt;P&lt;/em&gt; &lt; 0.01, *** &lt;em&gt;P&lt;/em&gt; &lt; 0.001.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F2.medium.gif" width="440" height="186"/><noscript><img class="highwire-fragment fragment-image" alt="FIG 2." src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F2.medium.gif" width="440" height="186"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download FIG 2." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG 2.</span> <p id="p-10" class="first-child">Increased replication capacity does not restore virus resistance to IFN-β. DBT cells were pretreated with the indicated concentrations of mouse IFN-β for 18 h and then infected with WT, ExoN(-), or ExoN(-) P250 virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected and the viral titers present determined by plaque assay. Raw viral titers (A) or the change in viral titers relative to untreated controls (B) are reported. Error bars indicate SEM (n = 4). Statistical significance compared to WT-MHV is denoted and was determined by Student's <em>t</em> – test. *, <em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, *** <em>P</em> &lt; 0.001.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-6" class="subsection"><h3>Nsp14 ExoN activity is required for replication in wild-type B6 BMMs</h3><p id="p-11">We next wanted to test whether ExoN activity was required for IFN resistance in primary innate immune cells, such as BMMs. Replication of WT-MHV in primary BMMs is well described, and data suggest that wild-type B6 BMMs (B6) express many PRRs and ISGs at a higher basal level than many mouse cell lines (<a id="xref-ref-3-4" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>, <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>). In contrast, BMMs lacking the IFNAR receptor (IFNAR-/-) have lower basal and expressed levels of ISGs; thus, making B6 and IFNAR-/-BMMs excellent cell types for interrogating the role of ExoN activity on viral replication and antagonism of the innate immune response (<a id="xref-ref-25-2" class="xref-bibr" href="#ref-25">25</a>). BMMs from B6 or IFNAR-/-mice were generated and infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. Samples were harvested at the indicated time points, and viral titers were determined by plaque assay (<a id="xref-fig-3-1" class="xref-fig" href="#F3">Fig. 3A</a>). WT-MHV replication increased gradually in both B6 and IFNAR-/-BMMs at each time-point post-infection. In contrast, ExoN(-) virus replication in B6 BMMs was only detectable at 6 and 9 h post-infection. However, when IFNAR-/- BMMs were infected with ExoN(-) virus, viral titers were partially restored and increased at each time point post-infection. To further test the replication of viruses lacking ExoN activity and the effect of an increased replication capacity in BMMs, B6 and IFNAR-/-BMMs were infected with WT-MHV or ExoN(-) P250 viruses at an MOI of 1 PFU/cell. Similar to <a id="xref-fig-3-2" class="xref-fig" href="#F3">Fig. 3A</a>, WT-MHV viral titers steadily increased in B6 and IFNAR-/-BMMs at each time-point post-infection (<a id="xref-fig-3-3" class="xref-fig" href="#F3">Fig. 3B</a>). However, similar to ExoN(-) virus, ExoN(-) P250 virus replication in B6 BMMs was restricted and not detected beyond 9 h post-infection. In addition, ExoN(-) P250 virus replication in IFNAR-/-BMMs was restored to similar levels as WT-MHV. These data show that ExoN activity is required for replication in B6 BMMs. Further, they suggest that restriction of ExoN(-) or ExoN(-) P250 is mediated by a gene or genes downstream of IFNAR.</p><div id="F3" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F3.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Replication of viruses lacking ExoN activity is restricted in wild-type B6 BMMs. B6 BMMs or IFNAR-/-BMMs were infected with WT-MHV or ExoN(-) virus (A) or WT-MHV or ExoN(-) P250 virus (B) at an MOI of 1 PFU/cell. At the indicated times post-infection, cell culture supernatant aliquots were collected and the viral titers present were determined by plaque assay. For each panel, error bars represent SEM (n = 6 to 7). ND = not detectable." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-998985183" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;Replication of viruses lacking ExoN activity is restricted in wild-type B6 BMMs. B6 BMMs or IFNAR-/-BMMs were infected with WT-MHV or ExoN(-) virus (A) or WT-MHV or ExoN(-) P250 virus (B) at an MOI of 1 PFU/cell. At the indicated times post-infection, cell culture supernatant aliquots were collected and the viral titers present were determined by plaque assay. For each panel, error bars represent SEM (n = 6 to 7). ND = not detectable.&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG 3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F3.medium.gif" width="238" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="FIG 3." src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F3.medium.gif" width="238" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download FIG 3." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG 3.</span> <p id="p-12" class="first-child">Replication of viruses lacking ExoN activity is restricted in wild-type B6 BMMs. B6 BMMs or IFNAR-/-BMMs were infected with WT-MHV or ExoN(-) virus (A) or WT-MHV or ExoN(-) P250 virus (B) at an MOI of 1 PFU/cell. At the indicated times post-infection, cell culture supernatant aliquots were collected and the viral titers present were determined by plaque assay. For each panel, error bars represent SEM (n = 6 to 7). ND = not detectable.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-7" class="subsection"><h3>Loss of ExoN activity does not result in the induction of IFN and replication is not rescued by RNase L/PKR deficiency</h3><p id="p-13">Upon detection of a pathogen-associated molecular pattern (PAMP) by innate sensors, signaling pathways lead to transcription factor activation and nuclear translocation resulting in expression of IFN-β mRNA (<a id="xref-ref-4-3" class="xref-bibr" href="#ref-4">4</a>). WT-MHV is well known to prevent or delay the induction of IFN expression (<a id="xref-ref-3-5" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-22-2" class="xref-bibr" href="#ref-22">22</a>). However, ExoN activity may help prevent the detection of a PAMP, namely dsRNA, which has been shown to be increased in an nsp15 EndoU mutant (<a id="xref-ref-12-2" class="xref-bibr" href="#ref-12">12</a>). Therefore, to determine whether the loss of ExoN activity resulted in the generation and subsequent detection of a PAMP, we determined the level of IFN-β gene expression in DBT cells infected with mock, WT-MHV, ExoN(-), or ExoN(-) P250 virus at an MOI of 0.1 PFU/cell (<a id="xref-fig-4-1" class="xref-fig" href="#F4">Fig. 4A</a>). In addition, we infected DBT cells with Sendai virus (SenV), a positive control and a potent inducer of IFN, at an MOI of 200 HA units/ml. SenV infection resulted in IFN expression by 3 h post-infection and peaked between 9 and 12 h post-infection prior to returning nearly to mock infected levels by 24 h post-infection, demonstrating that DBT cells are capable of expressing IFN-β. In contrast, no CoV infection, regardless of whether intact ExoN activity was present, resulted in IFN-β gene expression over mock-infected cells with the exception of WT-MHV at 3 h post-infection. Further, upon detection of dsRNA by OAS and subsequent activation of RNase L, viral and cellular RNAs are degraded as an antiviral mechanism (<a id="xref-ref-4-4" class="xref-bibr" href="#ref-4">4</a>). To determine whether infection with ExoN(-) virus activates RNase L, DBT cells were pretreated with 0 or 50 U/ml mouse IFN-β and infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell or transfected with 25μg/ml poly I:C, a dsRNA surrogate. At the indicated times post-infection, cell lysates were harvested, total RNA extracted, and the integrity of cellular rRNA determined using a bioanalyzer (<a id="xref-fig-4-2" class="xref-fig" href="#F4">Fig. 4B</a>). Transfection of DBT cells with poly I:C resulted in rRNA degradation, whereas, infection of DBT cells with WT-MHV or ExoN(-) virus did not result in rRNA degradation under any tested conditions. Lastly, when B6 or RNase L-/-/PKR-/-BMMs (RL-/-/PKR-/-) were infected with ExoN(-) virus, replication was restricted (<a id="xref-fig-4-3" class="xref-fig" href="#F4">Fig. 4C</a>). In contrast to infection of B6 BMMs, ExoN(-) viral titer from RL-/-/PKR-/-BMMs was detectable at 12 and 24 h post-infection. However, viral yield was minimal. These data suggest that loss of nsp14 ExoN activity does not lead to the transcriptional activation of IFN-β or a notable dsRNA sensor such as OAS/RNase L during infection of DBT cells. In addition, BMMs deficient in the antiviral effectors RNase L and PKR were not sufficient to restore ExoN(-) viral replication.</p><div id="F4" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F4.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Loss of ExoN activity does not result in the generation of a detectable PAMP. (A) DBT cells were infected with mock, WT, ExoN(-) or ExoN(-) P250 virus at an MOI of 0.1 PFU/cell or infected with Sendai virus at an MOI of 200 HA units/ml. At the indicated times post-infection, cell culture supernatants were removed, cell lysates were harvested, total RNA was extracted, cDNA was generated, and IFN-&#x3B2; expression relative to GAPDH was determined by qPCR. Error bars indicate SEM (n = 4). (B) DBT cells were pretreated for 18 h with 0 or 50U/ml mouse IFN-&#x3B2; and subsequently infected with WT-MHV or ExoN(-) virus or transfected with 25&#x3BC;g/ml poly I:C. At the indicated times post-infection, cell culture supernatants were removed, cell lysates harvested, and total RNA extracted. rRNA integrity was assessed using an Agilent Bioanlyzer. One representative image is shown for each sample from 2 independent experiments. Images spliced for labeling purposes. The averaged RNA integrity values for each condition are reported. (C) B6 BMMs or RL-/-/ PKR-/-BMMs were infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At the indicated times post-infection, cell culture supernatant aliquots were collected and the viral titers present were determined by plaque assay. Error bars represent SEM (n = 5). ND = not detectable." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-998985183" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;Loss of ExoN activity does not result in the generation of a detectable PAMP. (A) DBT cells were infected with mock, WT, ExoN(-) or ExoN(-) P250 virus at an MOI of 0.1 PFU/cell or infected with Sendai virus at an MOI of 200 HA units/ml. At the indicated times post-infection, cell culture supernatants were removed, cell lysates were harvested, total RNA was extracted, cDNA was generated, and IFN-&#x3B2; expression relative to GAPDH was determined by qPCR. Error bars indicate SEM (n = 4). (B) DBT cells were pretreated for 18 h with 0 or 50U/ml mouse IFN-&#x3B2; and subsequently infected with WT-MHV or ExoN(-) virus or transfected with 25&#x3BC;g/ml poly I:C. At the indicated times post-infection, cell culture supernatants were removed, cell lysates harvested, and total RNA extracted. rRNA integrity was assessed using an Agilent Bioanlyzer. One representative image is shown for each sample from 2 independent experiments. Images spliced for labeling purposes. The averaged RNA integrity values for each condition are reported. (C) B6 BMMs or RL-/-/ PKR-/-BMMs were infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At the indicated times post-infection, cell culture supernatant aliquots were collected and the viral titers present were determined by plaque assay. Error bars represent SEM (n = 5). ND = not detectable.&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG 4." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F4.medium.gif" width="218" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="FIG 4." src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F4.medium.gif" width="218" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F4.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download FIG 4." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG 4.</span> <p id="p-14" class="first-child">Loss of ExoN activity does not result in the generation of a detectable PAMP. (A) DBT cells were infected with mock, WT, ExoN(-) or ExoN(-) P250 virus at an MOI of 0.1 PFU/cell or infected with Sendai virus at an MOI of 200 HA units/ml. At the indicated times post-infection, cell culture supernatants were removed, cell lysates were harvested, total RNA was extracted, cDNA was generated, and IFN-β expression relative to GAPDH was determined by qPCR. Error bars indicate SEM (n = 4). (B) DBT cells were pretreated for 18 h with 0 or 50U/ml mouse IFN-β and subsequently infected with WT-MHV or ExoN(-) virus or transfected with 25μg/ml poly I:C. At the indicated times post-infection, cell culture supernatants were removed, cell lysates harvested, and total RNA extracted. rRNA integrity was assessed using an Agilent Bioanlyzer. One representative image is shown for each sample from 2 independent experiments. Images spliced for labeling purposes. The averaged RNA integrity values for each condition are reported. (C) B6 BMMs or RL-/-/ PKR-/-BMMs were infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At the indicated times post-infection, cell culture supernatant aliquots were collected and the viral titers present were determined by plaque assay. Error bars represent SEM (n = 5). ND = not detectable.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-8" class="subsection"><h3>IFN treatment does not substantially alter ExoN(-) viral RNA accumulation or particle release</h3><p id="p-15">Since ExoN activity is required for resistance to IFN but had no effect on IFN induction, we sought to discern the stage of viral replication that was restricted by IFN-β treatment. To determine the effect of IFN-β pretreatment on viral RNA accumulation, DBT cells were pretreated with 0 or 100 U/ml mouse IFN-β for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At the indicated times post-infection, the number of genomic RNA copies present were determined by qRT-PCR. IFN-β pretreatment had minimal effect on the accumulation of WT-MHV genomic RNA (<a id="xref-fig-5-1" class="xref-fig" href="#F5">Fig. 5A</a>). Whereas ExoN(-) genomic RNA accumulation is delayed relative to WT-MHV (<a id="xref-ref-15-3" class="xref-bibr" href="#ref-15">15</a>), pretreatment with IFN-β did not substantially decrease ExoN(-) genomic RNA levels (<a id="xref-fig-5-2" class="xref-fig" href="#F5">Fig. 5A</a>). In addition, we determined the effects of IFN-β pretreatment on the levels of subgenomic viral RNA. For both WT-MHV and ExoN(-) viruses, IFN-β pretreatment did not substantially reduce subgenomic RNA levels at any time-point (<a id="xref-fig-5-3" class="xref-fig" href="#F5">Fig. 5B</a>). These data indicate that IFN pretreatment did not result in the gross degradation or inhibition of ExoN(-) or ExoN(-) P250 viral RNA accumulation. While slight reductions in viral RNA could explain a small portion of the IFN phenotype, these data suggest that decreased replication or transcription is not the primary driver of ExoN(-) IFN sensitivity.</p><div id="F5" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F5.large.jpg?width=800&amp;height=600&amp;carousel=1" title="ExoN(-) viral RNA accumulation and particle release is marginally affected by IFN-&#x3B2; pretreatment. DBT cells were pretreated with 0 or 100U/ml mouse IFN-&#x3B2; for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At the indicated times post-infection, total cell lysates were harvested and RNA was extracted. The viral genomic RNA copies present relative to an RNA standard were determined by one-step qRT-PCR (A) or cDNA was generated and the subgenomic RNA copies relative to GAPDH were determined by qPCR (B). For each panel (A and B), error bars represent SEM (n= 6 to 9). DBT cells were pretreated with 0 or 100U/ml mouse IFN-&#x3B2; for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected. Equivalent volumes of cell culture supernatant for each sample were divided into two samples. For the first cell culture supernatant sample, total RNA was extracted and the number of virion genome RNA copies present (particles) was determined by one-step qRT-PCR (C) or reported as the change in virion genome RNA copies (D). Error bars represent SEM (n = 13 to 15). Statistical significance compared to untreated WT-MHV or ExoN(-) infection, respectively, is denoted and was determined by Student's t &#x2013; test. *** P &lt; 0.001." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-998985183" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;ExoN(-) viral RNA accumulation and particle release is marginally affected by IFN-&#x3B2; pretreatment. DBT cells were pretreated with 0 or 100U/ml mouse IFN-&#x3B2; for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At the indicated times post-infection, total cell lysates were harvested and RNA was extracted. The viral genomic RNA copies present relative to an RNA standard were determined by one-step qRT-PCR (A) or cDNA was generated and the subgenomic RNA copies relative to GAPDH were determined by qPCR (B). For each panel (A and B), error bars represent SEM (n= 6 to 9). DBT cells were pretreated with 0 or 100U/ml mouse IFN-&#x3B2; for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected. Equivalent volumes of cell culture supernatant for each sample were divided into two samples. For the first cell culture supernatant sample, total RNA was extracted and the number of virion genome RNA copies present (particles) was determined by one-step qRT-PCR (C) or reported as the change in virion genome RNA copies (D). Error bars represent SEM (n = 13 to 15). Statistical significance compared to untreated WT-MHV or ExoN(-) infection, respectively, is denoted and was determined by Student's &lt;em&gt;t&lt;/em&gt; &#x2013; test. *** &lt;em&gt;P&lt;/em&gt; &lt; 0.001.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG 5." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F5.medium.gif" width="424" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="FIG 5." src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F5.medium.gif" width="424" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F5.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download FIG 5." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F5.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG 5.</span> <p id="p-16" class="first-child">ExoN(-) viral RNA accumulation and particle release is marginally affected by IFN-β pretreatment. DBT cells were pretreated with 0 or 100U/ml mouse IFN-β for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At the indicated times post-infection, total cell lysates were harvested and RNA was extracted. The viral genomic RNA copies present relative to an RNA standard were determined by one-step qRT-PCR (A) or cDNA was generated and the subgenomic RNA copies relative to GAPDH were determined by qPCR (B). For each panel (A and B), error bars represent SEM (n= 6 to 9). DBT cells were pretreated with 0 or 100U/ml mouse IFN-β for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected. Equivalent volumes of cell culture supernatant for each sample were divided into two samples. For the first cell culture supernatant sample, total RNA was extracted and the number of virion genome RNA copies present (particles) was determined by one-step qRT-PCR (C) or reported as the change in virion genome RNA copies (D). Error bars represent SEM (n = 13 to 15). Statistical significance compared to untreated WT-MHV or ExoN(-) infection, respectively, is denoted and was determined by Student's <em>t</em> – test. *** <em>P</em> &lt; 0.001.</p><div class="sb-div caption-clear"></div></div></div><p id="p-17">Since pretreatment of DBT cells with IFN-β does not grossly alter ExoN(-) viral RNA accumulation but does reduce ExoN(-) viral titers, we sought to determine whether IFN pretreatment prior to infection resulted in a measurable difference in the number of viral particles released from WT-MHV or ExoN(-) infected cells. DBT cells were pretreated with 0 or 100 U/ml mouse IFN-β for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were harvested and an aliquot of two equal volumes were removed. From the first volume of each sample, RNA was extracted and used to perform one-step qRT-PCR to determine the number of genome RNAs present, and hence, the number of genome RNA containing particles present in the given volume of supernatant (<a id="xref-fig-5-4" class="xref-fig" href="#F5">Fig. 5C</a>). The second volume was saved for a plaque assay as described below. Pretreatment of cells with IFN-β resulted in approximately a 1 log<sub>10</sub> decrease in the number of supernatant viral particles for both WT-MHV and ExoN(-) viruses compared to the number of supernatant viral particles from untreated cells, demonstrating that IFN pretreatment affects the release of WT-MHV and ExoN(-) virus particles equally (<a id="xref-fig-5-5" class="xref-fig" href="#F5">Fig. 5D</a>). Thus, these data suggest that IFN pretreatment does not restrict the primary replication of viruses lacking ExoN activity, but rather, renders them potentially inadequate for subsequent infection.</p></div><div id="sec-9" class="subsection"><h3>ExoN(-) virus progeny generated in the presence of an IFN induced-antiviral state have decreased specific infectivity and fitness upon subsequent infection</h3><p id="p-18">While many ISGs antagonize viral replication, some could alter the infectivity of progeny particles (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>, <a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>). To test whether IFN pretreatment affected the infectivity of ExoN(-) viral particles, the remaining cell culture supernatant volume described above was used to perform a plaque assay to determine the number of PFUs present (data not shown). Using the number of particles determined in <a id="xref-fig-5-6" class="xref-fig" href="#F5">Fig. 5C</a> and the number of PFUs present in an equivalent volume; we calculated the specific infectivity, or particle-to-PFU ratio, of each virus generated under each condition (<a id="xref-fig-6-1" class="xref-fig" href="#F6">Fig. 6A</a>). Regardless of IFN-β pretreatment during the initial infection, the specific infectivity of WT-MHV was approximately 10 particles per 1 PFU upon subsequent infection. Infection of untreated DBT cells with ExoN(-) virus resulted in a similar particle to PFU ratio as WT-MHV during subsequent infection. In contrast, when DBT cells were pretreated with IFN-β prior to initial infection with ExoN(-) virus, the resulting specific infectivity of ExoN(-) virus was 100 particles per 1 PFU, a significant decrease in specific infectivity. Therefore, ExoN(-) virus generated in the presence of an IFN-β-mediated antiviral state requires 10-fold more genome RNA containing particles to generate 1 PFU than WT-MHV generated in cells pretreated with or without IFN or ExoN(-) virus generated in untreated cells. These data suggest that the IFN-mediated restriction of ExoN(-) virus in DBT cells occurs at the level of subsequent infection by reducing particle infectivity.</p><div id="F6" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F6.large.jpg?width=800&amp;height=600&amp;carousel=1" title="ExoN(-) viruses generated in the presence of an antiviral state have decreased specific infectivity and are less fit relative to untreated. (A) DBT cells were pretreated with 0 or 100U/ml mouse IFN-&#x3B2; for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected. Equivalent volumes of cell culture supernatant for each sample were divided into two samples. For the first cell culture supernatant sample, total RNA was extracted and the number of virion genome RNA copies present (particles) was determined by one-step qRT-PCR [Fig. 5C]. For the second cell culture supernatant sample, the viral titer present was determined by plaque assay (PFUs) (data not shown). The particle to PFU ratio for each virus and treatment was calculated by dividing the number of particles by the number of PFUs. Error bars represent SEM (n = 13 to 15). (B) DBT cells were pretreated with 0 or 100 U/ml mouse IFN-&#x3B2; for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were harvested for each virus and treatment group and the number of virion genome RNA copies present (particles) in the supernatant was determined by one-step qRT-PCR. Using the determined number of particles, an equivalent number of virus particles from each virus and treatment group were mixed with an equal number of WT silent or ExoN(-) silent virus particles. This mixture was then used to infect a fresh monolayer of untreated DBT cells. At 24 h post-infection, cell culture supernatants were collected, RNA was extracted, and the number of virion genome RNA copies for each original virus and treatment group relative to their respective silent standard viruses was determined by one-step qRT-PCR and is reported as the change in fitness relative to the silent virus standard. Error bars represent SEM (n = 6). For each panel, statistical significance compared to untreated WT-MHV or ExoN(-) infection, respectively, is denoted and was determined by Student's t &#x2013; test. *, P &lt; 0.05, *** P &lt; 0.001, n.s. = not significant." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-998985183" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;ExoN(-) viruses generated in the presence of an antiviral state have decreased specific infectivity and are less fit relative to untreated. (A) DBT cells were pretreated with 0 or 100U/ml mouse IFN-&#x3B2; for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected. Equivalent volumes of cell culture supernatant for each sample were divided into two samples. For the first cell culture supernatant sample, total RNA was extracted and the number of virion genome RNA copies present (particles) was determined by one-step qRT-PCR [Fig. 5C]. For the second cell culture supernatant sample, the viral titer present was determined by plaque assay (PFUs) (data not shown). The particle to PFU ratio for each virus and treatment was calculated by dividing the number of particles by the number of PFUs. Error bars represent SEM (n = 13 to 15). (B) DBT cells were pretreated with 0 or 100 U/ml mouse IFN-&#x3B2; for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were harvested for each virus and treatment group and the number of virion genome RNA copies present (particles) in the supernatant was determined by one-step qRT-PCR. Using the determined number of particles, an equivalent number of virus particles from each virus and treatment group were mixed with an equal number of WT silent or ExoN(-) silent virus particles. This mixture was then used to infect a fresh monolayer of untreated DBT cells. At 24 h post-infection, cell culture supernatants were collected, RNA was extracted, and the number of virion genome RNA copies for each original virus and treatment group relative to their respective silent standard viruses was determined by one-step qRT-PCR and is reported as the change in fitness relative to the silent virus standard. Error bars represent SEM (n = 6). For each panel, statistical significance compared to untreated WT-MHV or ExoN(-) infection, respectively, is denoted and was determined by Student's &lt;em&gt;t&lt;/em&gt; &#x2013; test. *, &lt;em&gt;P&lt;/em&gt; &lt; 0.05, *** &lt;em&gt;P&lt;/em&gt; &lt; 0.001, n.s. = not significant.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG 6." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F6.medium.gif" width="440" height="242"/><noscript><img class="highwire-fragment fragment-image" alt="FIG 6." src="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F6.medium.gif" width="440" height="242"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F6.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download FIG 6." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2017/08/29/182196/F6.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG 6.</span> <p id="p-19" class="first-child">ExoN(-) viruses generated in the presence of an antiviral state have decreased specific infectivity and are less fit relative to untreated. (A) DBT cells were pretreated with 0 or 100U/ml mouse IFN-β for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were collected. Equivalent volumes of cell culture supernatant for each sample were divided into two samples. For the first cell culture supernatant sample, total RNA was extracted and the number of virion genome RNA copies present (particles) was determined by one-step qRT-PCR [<a id="xref-fig-5-7" class="xref-fig" href="#F5">Fig. 5C</a>]. For the second cell culture supernatant sample, the viral titer present was determined by plaque assay (PFUs) (data not shown). The particle to PFU ratio for each virus and treatment was calculated by dividing the number of particles by the number of PFUs. Error bars represent SEM (n = 13 to 15). (B) DBT cells were pretreated with 0 or 100 U/ml mouse IFN-β for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, cell culture supernatants were harvested for each virus and treatment group and the number of virion genome RNA copies present (particles) in the supernatant was determined by one-step qRT-PCR. Using the determined number of particles, an equivalent number of virus particles from each virus and treatment group were mixed with an equal number of WT silent or ExoN(-) silent virus particles. This mixture was then used to infect a fresh monolayer of untreated DBT cells. At 24 h post-infection, cell culture supernatants were collected, RNA was extracted, and the number of virion genome RNA copies for each original virus and treatment group relative to their respective silent standard viruses was determined by one-step qRT-PCR and is reported as the change in fitness relative to the silent virus standard. Error bars represent SEM (n = 6). For each panel, statistical significance compared to untreated WT-MHV or ExoN(-) infection, respectively, is denoted and was determined by Student's <em>t</em> – test. *, <em>P</em> &lt; 0.05, *** <em>P</em> &lt; 0.001, n.s. = not significant.</p><div class="sb-div caption-clear"></div></div></div><p id="p-20">Next, we tested whether the effects of IFN on ExoN(-) viruses were intrinsic to the viruses produced. To do so, we performed a co-infection assay, which utilized WT-MHV and ExoN(-) viruses harboring 10 silent mutations in the nsp2-coding region (WT silent and ExoN(-) silent, respectively) along with WT-MHV and ExoN(-) viruses. The genome RNAs of the silent viruses are recognized exclusively by a separate probe than the one used to detect the “WT” nsp2 probe-binding region of WT-MHV or ExoN(-) viruses (<a id="xref-ref-24-2" class="xref-bibr" href="#ref-24">24</a>). Thus, allowing WT silent and ExoN(-) silent to act as internal controls for a co-infection assay under identical conditions. DBT cells were pretreated with 0 or 100 U/ml mouse IFN-β for 18 h and subsequently infected with WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. At 12 h post-infection, total cell culture supernatants were collected. The number of viral particles present in a representative aliquot was determined from purified virion genome RNA by one-step qRT-PCR. In addition, we determined the number of genome RNA containing particles in an equivalent volume of WT silent or ExoN(-) silent viral p1 stock tubes. Using the calculated number of genome RNA-containing viral particles, we added an equal number of WT-MHV viral particles generated in the absence of IFN pretreatment to WT silent viral particles and an equal number of WT-MHV viral particles generated in the presence of IFN pretreatment to WT silent viral particles. This same set-up was repeated for ExoN(-) viral particles generated in the presence or absence of IFN pretreatment with ExoN(-) silent viral particles. Finally, each combination was used to infect a fresh monolayer of untreated DBT cells. At 24 h post-co-infection, total cell culture supernatants were collected and virion genome RNA was extracted to determine the number of supernatant viral particles present from each combination of input viruses by one-step qRT-PCR and is reported as the change in fitness relative to the respective silent virus standard (<a id="xref-fig-6-2" class="xref-fig" href="#F6">Fig. 6B</a>). WT-MHV particles generated in the presence of IFN pretreatment generated a similar number of viral particles over the course of co-infection as WT-MHV generated in the absence of IFN pretreatment relative to their respective silent standards. However, the number of viral particles present from ExoN(-) virus generated in the presence of IFN pretreatment during the course of co-infection decreased by approximately 1.5 log<sub>10</sub> in comparison with ExoN(-) viral particles generated in the absence of IFN pretreatment relative to their respective silent standards. These data indicate that a loss in nsp14 ExoN activity sensitizes viruses to IFN pretreatment and reduces the infectivity and fitness of progeny during subsequent rounds of infection in the absence of an antiviral state.</p></div></div><div class="section" id="sec-10"><h2 class="">DISCUSSION</h2><p id="p-21">CoVs encode multiple IFN antagonists that prevent the induction of or mediate resistance to the innate immune response; thus, allowing efficient viral replication early during infection (<a id="xref-ref-3-6" class="xref-bibr" href="#ref-3">3</a>). Moreover, an insufficient innate immune response has been proposed to be a major contributor to SARS-CoV pathogenesis (<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>). In this study, we sought to determine the contributions of nsp14 ExoN activity in the induction of and resistance to the innate immune response. We demonstrate that ExoN(-) virus is sensitive to pretreatment with IFN-β. Because ExoN3 (-) and ExoN(-) P250 viruses were also sensitive to the effects of IFN, we conclude that IFN sensitivity is specifically due to loss of ExoN activity.</p><p id="p-22">Because the ExoN activity of the Lassa fever virus nucleoprotein degrades dsRNA intermediates (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>, <a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>), we hypothesized that CoV nsp14 ExoN could function in a similar manner. If nsp14 ExoN is degrading viral dsRNA, ExoN inactivation should increase intracellular dsRNA accumulation, resulting in a concomitant increase in IFN-β expression or activation of RNase L during infection. We neither observed IFN-β up-regulation nor RNase L activation over the course of ExoN(-) virus infection (<a id="xref-fig-4-4" class="xref-fig" href="#F4">Fig. 4A</a> and B), and rRNA was intact at all time-points tested (<a id="xref-fig-4-5" class="xref-fig" href="#F4">Fig. 4B</a>). Therefore, at least two possible explanations exist: 1.) ExoN does not function to degrade dsRNA or 2.) ExoN does degrade dsRNA, but the detection of this PAMP is unchanged during ExoN(-) virus infection due to sufficient antagonism by other CoV proteins. Basal OAS expression levels correlate with RNase L activation (<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>). Thus, we pretreated DBTs with IFN-β to up-regulate OAS and RNase L expression. However, rRNA degradation was only observed in cells transfected with poly I:C (<a id="xref-fig-4-6" class="xref-fig" href="#F4">Fig. 4B</a>). Further, nsp15 EndoU and NS2 phosphodiesterase activities were intact during all of our experiments. Thus, it is possible that in the absence of nsp14 ExoN activity, other CoV innate antagonists were sufficient to prevent innate detection by the cell or prevent the induction of a detectable signal in the experiments we performed. However, one would expect the endonucleolytic products of nsp15 to be smaller dsRNAs that could still activate RIG-I or MDA5, similar to RNase L products, unless another RNA degradation mechanism were in place (<a id="xref-ref-4-5" class="xref-bibr" href="#ref-4">4</a>, <a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a>). In addition, despite an intact NS2 phosphodiesterase, nsp15 mutants still activate RNase L-mediated rRNA degradation (<a id="xref-ref-12-3" class="xref-bibr" href="#ref-12">12</a>). Lastly, when RNaseL-/-/ PKR-/-BMMs were infected with ExoN(-) virus, viral replication was not rescued, suggesting that RNase L and PKR are not required for ExoN(-) virus restriction (<a id="xref-fig-4-7" class="xref-fig" href="#F4">Fig. 4C</a>). Moreover, these data suggest dsRNA is not detected and the antiviral effectors RNaseL and PKR are not activated during ExoN(-) virus infection.</p><p id="p-23">During our study, Becares et al. reported that a TGEV nsp14 zinc-finger mutant modulated the innate immune response of swine testis cells by reducing the levels of dsRNA and induction of IFN (<a id="xref-ref-21-2" class="xref-bibr" href="#ref-21">21</a>). Unlike TGEV, <em>Betacoronaviruses</em> such as SARS-CoV and MHV, do not induce IFN expression in most cell types (<a id="xref-ref-1-4" class="xref-bibr" href="#ref-1">1</a>-<a id="xref-ref-3-7" class="xref-bibr" href="#ref-3">3</a>) (Fig.4A). Interestingly, TGEV ExoN active site mutants were non-viable; although, this is not the first report of non-viable ExoN active site residue mutants in <em>Alphacoronaviruses</em> (<a id="xref-ref-21-3" class="xref-bibr" href="#ref-21">21</a>). In the initial report of CoV nsp14 ExoN activity, human CoV 229E ExoN active site mutants were also non-viable, suggesting a common essential function for nsp14 ExoN in <em>Alphacoronavirus</em> replication and/or innate antagonism (<a id="xref-ref-13-4" class="xref-bibr" href="#ref-13">13</a>). Altogether, the possibility of a common innate immune antagonism function for nsp14 across <em>Alpha</em>-and <em>Beta</em>-CoVs is apparent but clearly differing requirements exist that may be dependent on the CoV genus and cell types used.</p><p id="p-24">Our results clearly demonstrate that viruses lacking ExoN activity are sensitive to IFN-β pretreatment in a dose-dependent manner (<a id="xref-fig-1-5" class="xref-fig" href="#F1">Fig. 1A</a>, C and <a id="xref-fig-2-3" class="xref-fig" href="#F2">Fig. 2</a>). Further, replication of viruses lacking ExoN activity was dependent on the capacity of BMMs to express genes downstream of IFNAR signaling (<a id="xref-fig-3-4" class="xref-fig" href="#F3">Fig. 3</a>). This is due to the fact that B6 and IFNAR-/-cells have different levels of basal ISG expression and thus, two very different intracellular environments for viral replication to occur (<a id="xref-ref-3-8" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-25-3" class="xref-bibr" href="#ref-25">25</a>, <a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">26</a>). In IFNAR-/-BMMs, ExoN(-) and ExoN(-) P250 virus replication capacity was restored to levels approaching or exceeding WT-MHV levels (<a id="xref-fig-3-5" class="xref-fig" href="#F3">Fig. 3</a>). Further, our specific infectivity (<a id="xref-fig-6-3" class="xref-fig" href="#F6">Fig. 6A</a>) and co-infection (<a id="xref-fig-6-4" class="xref-fig" href="#F6">Fig. 6B</a>) data show that ExoN(-) virus generated in the presence of an antiviral state is less viable upon subsequent infection. Altogether, our results suggest that an ISG or ISGs is (are) acting on ExoN(-) virus, specifically resulting in progeny that are less viable upon subsequent infection. Thus, it will be interesting to determine the specific ISG or ISGs responsible for mediating the observed restriction. In addition, it will be important to determine whether a greater proportion of the incoming ExoN(-) viral particles are strictly non-viable or whether cells are now sensing the progeny ExoN(-) viruses and inhibiting replication. Due to the pleiotropic nature of IFN-β, more than one mechanism may be acting. To date, the majority of our understanding of nsp14 ExoN activity is in the context of proofreading during CoV replication (<a id="xref-ref-13-5" class="xref-bibr" href="#ref-13">13</a>, <a id="xref-ref-15-4" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-16-3" class="xref-bibr" href="#ref-16">16</a>, <a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a>). CoVs lacking ExoN activity demonstrate an increase in mutation frequency relative to WT (<a id="xref-ref-15-5" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-16-4" class="xref-bibr" href="#ref-16">16</a>). Thus, it is possible that ExoN(-) virus replication in IFN pretreated cells results in further alteration of ExoN(-) virus mutation frequency. Certainly, an increase or decrease in mutation frequency could impair viral replication during a subsequent infection. In addition, an ISG may act to hypermutate the large CoV genome in the absence of ExoN activity, rendering viral progeny less viable. ISGs that increase viral mutation frequency have been described such as adenosine deaminase acting on RNA 1 (ADAR1) and apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G) (<a id="xref-ref-27-2" class="xref-bibr" href="#ref-27">27</a>, <a id="xref-ref-28-2" class="xref-bibr" href="#ref-28">28</a>). Further, another ISG, SAMHD1, may inhibit HIV replication by limiting nucleotide pools, a known contributor to increased viral mutation frequency (<a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a>-<a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a>). Moreover, other possible mechanisms outside of altered mutation frequency exist. For instance, in the absence of ExoN activity, terminal RNA modifications, recombination, and/or replicase protein interactions mediated by nsp14 ExoN may be disrupted to a greater extent in the presence of an IFN-β-mediated antiviral state.</p><p id="p-25">Since CoVs encode the largest genome known for RNA viruses, they have the luxury of encoding multiple IFN antagonists that limit the capacity of a cell to detect and respond to infection. Collectively, our data suggest that MHV nsp14 ExoN activity is a contributor to CoV innate immune antagonism. We clearly demonstrate that viruses lacking ExoN activity are sensitive to the effects of an IFN-β-mediated antiviral state. Further, our data reveal a critical role for nsp14 ExoN activity in CoV replication and provide additional rationale for targeting nsp14 ExoN activity as a means of viral attenuation. Our future studies will probe the specific mechanism of restriction for viruses lacking ExoN activity and assess how the requirement of ExoN activity for resistance to innate immunity can be utilized for treatment during human coronavirus infections.</p></div><div class="section" id="sec-11"><h2 class="">MATERIALS AND METHODS</h2><div id="sec-12" class="subsection"><h3>Cell culture</h3><p id="p-26">Murine delayed brain tumor (DBT) cells (<a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a>) and baby hamster kidney 21 cells expressing the MHV receptor (BHK-R) (<a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a>) were maintained at 37°C in Dulbecco's modified Eagle medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS; Invitrogen), 100 U/ml penicillin and streptomycin (Gibco), and 0.25 μg/ml amphotericin B (Corning). BHKR cells were further supplemented with 0.8 mg/ml of G418 (Mediatech).</p></div><div id="sec-13" class="subsection"><h3>Cloning, recovery, and verification of mutant viruses</h3><p id="p-27">Recombinant MHV strain A59 (GenBank accession number <a class="external-ref external-ref-type-gen" href="/lookup/external-ref?link_type=GEN&amp;access_num=AY910861&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom">AY910861</a>) has been previously described (<a id="xref-ref-37-2" class="xref-bibr" href="#ref-37">37</a>). ExoN(-) (nsp14 D89A and E91A) has been previously described (<a id="xref-ref-15-6" class="xref-bibr" href="#ref-15">15</a>). To generate ExoN(-) P250 virus, sub-confluent monolayers of DBT cells in 25cm<sup>2</sup> flasks were infected using the ExoN(-) parental stock and blindly passaged for a total of 250 passages (<a id="xref-ref-24-3" class="xref-bibr" href="#ref-24">24</a>). For ExoN3 (-) virus (nsp14 D272A), site-directed mutagenesis was used to engineer point mutations in the MHV genome cDNA F fragment plasmid using the MHV infectious clone reverse genetics system (<a id="xref-ref-37-3" class="xref-bibr" href="#ref-37">37</a>). ExoN3 (-) mutant virus was recovered using BHK-R cells following electroporation of <em>in vitro</em>-transcribed genomic RNA. Recovered ExoN3 (-) virus was sequenced (GenHunter Corporation, Nashville, TN) to verify the engineered mutations were present and to ensure that no additional mutations were introduced.</p></div><div id="sec-14" class="subsection"><h3>Interferon-β sensitivity assays</h3><p id="p-28">Sub-confluent DBT cells were treated for 18 h with the indicated concentrations of mouse IFN-β (PBL Assay Science) prior to infection with virus at a multiplicity of infection (MOI) of 1 plaque-forming unit (PFU) per cell at 37°C for 45 min. After incubation, inocula were removed, cells were washed with PBS, and fresh medium was added. Cell culture supernatants were collected at 12 h post-infection, and viral titers were determined by plaque assay (<a id="xref-ref-15-7" class="xref-bibr" href="#ref-15">15</a>).</p></div><div id="sec-15" class="subsection"><h3>5-FU sensitivity assays</h3><p id="p-29">Sub-confluent DBT cells were treated with DMEM supplemented to contain the indicated concentrations of 5-fluorouracil [(5-FU), Sigma] or DMSO alone at 37<strong>°</strong>C for 30 min. After incubation, drug was removed and cells were infected with virus at an MOI of 1 PFU/cell at 37<strong>°</strong>C for 1 h. Inocula were removed, and cells were incubated in medium containing 5-FU or DMSO. Cell culture supernatants were collected at 12 h post-infection, and viral titers were determined by plaque assay.</p></div><div id="sec-16" class="subsection"><h3>Virus replication kinetics</h3><p id="p-30">Bone-marrow derived macrophages (BMMs) were generated from the hind limbs of WT, IFNAR-/-, or RNaseL-/-/ PKR-/-C57/B6 mice as previously described (<a id="xref-ref-11-2" class="xref-bibr" href="#ref-11">11</a>). BMMs were infected with virus at an MOI of 1 PFU/cell at 37°C for 1 h. After incubation, inocula were removed, cells were washed with 3 times with PBS, and fresh medium was added. At the indicated times post-infection, cell culture supernatant aliquots were collected and viral titers determined by plaque assay.</p></div><div id="sec-17" class="subsection"><h3>Interferon-β induction assays</h3><p id="p-31">Sub-confluent DBT cells were infected with mock, WT, ExoN(), or ExoN(-) P250 virus at an MOI of 0.1 PFU/cell or with Sendai virus (SenV) at an MOI of 200 HA (hemagglutination units)/ml at 37°C for 45 min. Inocula were removed, cells were washed with PBS, and fresh medium was added. At the indicated times post-infection, cell culture supernatants were removed and cell lysates were harvested by adding 1ml TRIzol reagent. Total RNA present in the lysates was purified using the phenol/chloroform method. cDNA was generated by reverse transcriptase-polymerase chain reaction (RT-PCR) using 1μg of total RNA as previously described (<a id="xref-ref-16-5" class="xref-bibr" href="#ref-16">16</a>). Mouse IFN-β expression levels were determined relative to GAPDH by qPCR using the Applied Biosciences 7500 Real-Time PCR System with Power SYBR Green PCR Master Mix and IFN-β primers: FWD: 5'-TCCGCCCTGTAGGTGAGGTTGAT-3' and REV: 5'-GTTCCTGCTGTGCTTCTCCACCA-3' and GAPDH primers previously reported (<a id="xref-ref-16-6" class="xref-bibr" href="#ref-16">16</a>).</p></div><div id="sec-18" class="subsection"><h3>Determination of rRNA integrity</h3><p id="p-32">Sub-confluent monolayers of DBT cells were treated with 0 or 50 U/ml mouse IFN-β for 18 h prior to being infected with virus at an MOI of 1 PFU/cell at 37°C for 45 min. After incubation, inocula were removed, cells were washed with PBS, and fresh medium was added. At the indicated times post-infection, cell culture supernatants were removed and total RNA was harvested by adding 1ml TRIzol reagent. For a positive control, cells were transfected with 25ug/ml polyI:C (Sigma) using Lipofectamine 2000 (Thermo Fisher Scientific). Total RNA from all samples was purified using the Purelink RNA Mini Purification System (Life Technologies) by following the manufacturers instructions. Upon purification, total RNA was analyzed on an Agilent Bioanalyzer by the Vanderbilt VANTAGE core facility and the rRNA integrity reported.</p></div><div id="sec-19" class="subsection"><h3>Quantification of viral genomic RNA by qRT-PCR</h3><p id="p-33">The quantification of viral genomic RNA has been previously described (<a id="xref-ref-14-2" class="xref-bibr" href="#ref-14">14</a>). Briefly, an RNA standard was prepared using the MHV A fragment (<a id="xref-ref-37-4" class="xref-bibr" href="#ref-37">37</a>) and a standard curve was generated using 10-fold dilutions from 10<sup>3</sup> to 10<sup>8</sup> copies. A 5' 6-carboxyfluorescein (FAM)-labeled probe (5'-TTCTGACAACGGCTACACCCAACG-3' [Biosearch Technologies]) was used with forward (5'-AGAAGGTTACTGGCAACTG-3') and reverse (5'-TGTCCACGGCTAAATCAAAC-3') nsp2 specific primers. The final volume for each reaction was 20 μl with 150 nM probe, 900 nM each primer, 2 μl sample RNA, and 10 μl 2X ToughMix, one-step, low ROX enzyme mix (Quantas) per reaction. Samples were quantified using an Applied Biosciences 7500 Real-Time PCR System with the conditions 55°C for 10 min, 95°C for 5 min, 95°C for 30 s, and 60°C for 1 min, with the last two steps repeated 40 times. The standard curve was plotted using GraphPad Prism 6 software, and genomes/μl were calculated.</p></div><div id="sec-20" class="subsection"><h3>Quantification of subgenomic RNA by qPCR</h3><p id="p-34">Sub-confluent DBT cells were treated with 0 or 100 U/mL mouse IFN-β for 18 h prior to being infected with virus at an MOI of 1 PFU/cell at 37°C for 45 min. After incubation, inocula were removed, cells were washed with PBS, and fresh medium was added. At the indicated times post-infection, cell culture supernatants were removed and total RNA was harvested by adding 1ml TRIzol reagent. Total RNA was extracted using the Purelink RNA mini purification system by following the manufacturers instructions. cDNA was generated by RT-PCR using 1ug of total RNA as previously described (<a id="xref-ref-16-7" class="xref-bibr" href="#ref-16">16</a>). Primers used to detect subgenomic nucleocapsid and GAPDH gene expression have been reported (<a id="xref-ref-16-8" class="xref-bibr" href="#ref-16">16</a>, <a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a>). Subgenomic (N) expression levels relative to GAPDH were determined using the Applied Biosciences 7500 Real-Time PCR System with Power SYBR Green PCR Master Mix.</p></div><div id="sec-21" class="subsection"><h3>Determination of specific infectivity</h3><p id="p-35">Sub-confluent monolayers of DBT cells were infected with virus at an MOI of 1 PFU/cell at 37°C for 45 min. After incubation, inocula were removed, cells were washed with PBS, and fresh medium was added. At 12 h post-infection, cell culture supernatants were collected, and viral titers were determined by plaque assay. Supernatants also were used for RNA genome isolation by adding 100 μl supernatant to 900 μl TRIzol reagent, chloroform extraction by phase separation, and final purification using the PureLink RNA Mini Purification System. Genome RNA was quantified using one-step qRT-PCR as described above, and the particle to PFU ratio was calculated.</p></div><div id="sec-22" class="subsection"><h3>Co-infection assay</h3><p id="p-36">Sub-confluent monolayers of DBT cells were treated with 0 or 100 U/ml mouse IFN-β for 18 h prior to being infected with virus at an MOI of 1 PFU/cell at 37°C for 45 min. After incubation, inocula were removed, cells were washed with PBS, and fresh medium was added. At 12 h post-infection, cell culture supernatants were removed and 100 μl of supernatant was added to 900 μl TRIzol reagent. Viral genome RNA was purified and the number of viral genome RNA copies present relative to an RNA standard curve were determined as described above. Based on the number of viral genome RNA copies determined by qRT-PCR, an equal number of virus particles from each virus and each condition were combined with an equal number of WT silent or ExoN(-) silent virus particles, respectively. WT silent and ExoN(-) silent viruses were engineered to harbor 10 silent mutations in the probe-binding region of nsp2, allowing separate detection from WT-MHV or ExoN(-) virus genomes, respectively, using a separate probe upon co-infection (<a id="xref-ref-24-4" class="xref-bibr" href="#ref-24">24</a>). Next, a fresh, sub-confluent monolayer of DBT cells were co-infected with each combination of viruses at 37°C for 45 min. After incubation, inocula were removed, cells were washed with PBS, and fresh medium was added. At 24 h post-infection, cell culture supernatants were removed and 100 μl of supernatant was added to 900 μl TRIzol reagent. Viral genome RNA was purified. The number of viral genome RNA copies of both reference and silent viruses were determined relative to the appropriate standard curve. The number of viral genome RNA copies relative to the number of silent virus genome RNA copies was determined for each virus and condition. Values are reported as the change in fitness relative to the silent virus.</p></div><div id="sec-23" class="subsection"><h3>Statistical analysis</h3><p id="p-37">Statistical tests were applied as noted in the respective figure legends and were determined using GraphPad Prism 6 software (La Jolla, CA).</p></div></div><div class="section ack" id="ack-1"><h2 class="">ACKNOWLEDGMENTS</h2><p id="p-38">We thank members of the Vanderbilt Technologies for Advanced Genomics (VANTAGE) core for rRNA integrity determination services. We thank fellow members of the Denison and Weiss laboratories, specifically Maria Agostini, for helpful discussions. This work was supported by Public Health Service awards T32 HL07751 (J.B.C.) from the National Heart, Lung, and Blood Institute, R01 AI108197 (M.R.D.), and R01 AI104887 (S.R.W.) from the National Institute of Allergy and Infectious Diseases. Additional support was provided by the Elizabeth B. Lamb Center for Pediatric Research.</p></div><div class="section ref-list" id="ref-list-1"><h2 class="">References</h2><ol class="cit-list ref-use-labels"><li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text" id="ref-1">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.1" data-doi="10.1128/JVI.00013-07"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Roth-Cross</span>  <span class="cit-name-given-names">JK</span></span>, <span class="cit-auth"><span class="cit-name-surname">Martínez-Sobrido</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Scott</span>  <span class="cit-name-given-names">EP</span></span>, <span class="cit-auth"><span class="cit-name-surname">García-Sastre</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>. <span class="cit-pub-date">2007</span>. <span class="cit-article-title">Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels</span>. <abbr class="cit-jnl-abbrev">J Virol</abbr> <span class="cit-vol">81</span>:<span class="cit-fpage">7189</span>–<span class="cit-lpage">7199</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00013-07%26rft_id%253Dinfo%253Apmid%252F17459917%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI4MS8xMy83MTg5IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTcvMDgvMjkvMTgyMTk2LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">2.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-182196v1.2" data-doi="10.1016/j.virusres.2007.03.015"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Frieman</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Heise</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baric</span>  <span class="cit-name-given-names">R.</span></span> <span class="cit-pub-date">2008</span>. <span class="cit-article-title">SARS coronavirus and innate immunity</span>. <abbr class="cit-jnl-abbrev">Virus Res</abbr>. <span class="cit-vol">133</span>:<span class="cit-fpage">101</span>–<span class="cit-lpage">112</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirus%2Bresearch%26rft.stitle%253DVirus%2BRes%26rft.aulast%253DFrieman%26rft.auinit1%253DM.%26rft.volume%253D133%26rft.issue%253D1%26rft.spage%253D101%26rft.epage%253D112%26rft.atitle%253DSARS%2Bcoronavirus%2Band%2Binnate%2Bimmunity.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.virusres.2007.03.015%26rft_id%253Dinfo%253Apmid%252F17451827%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.virusres.2007.03.015&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=17451827&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text" id="ref-3">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.3" data-doi="10.3390/v1030689"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Rose</span>  <span class="cit-name-given-names">KM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>. <span class="cit-pub-date">2009</span>. <span class="cit-article-title">Murine Coronavirus Cell Type Dependent Interaction with the Type I Interferon Response</span>. <abbr class="cit-jnl-abbrev">Viruses</abbr> <span class="cit-vol">1</span>:<span class="cit-fpage">689</span>–<span class="cit-lpage">712</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DViruses%26rft.aulast%253DRose%26rft.auinit1%253DK.%2BM.%26rft.volume%253D1%26rft.issue%253D3%26rft.spage%253D689%26rft.epage%253D712%26rft.atitle%253DMurine%2BCoronavirus%2BCell%2BType%2BDependent%2BInteraction%2Bwith%2Bthe%2BType%2BI%2BInterferon%2BResponse.%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fv1030689%26rft_id%253Dinfo%253Apmid%252F20221421%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3390/v1030689&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=20221421&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text" id="ref-4">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.4" data-doi="10.1146/annurev-immunol-032713-120231"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Schneider</span>  <span class="cit-name-given-names">WM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Chevillotte</span>  <span class="cit-name-given-names">MD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rice</span>  <span class="cit-name-given-names">CM</span></span>. <span class="cit-pub-date">2014</span>. <span class="cit-article-title">Interferon-stimulated genes: a complex web of host defenses</span>. <abbr class="cit-jnl-abbrev">Annu. Rev. Immunol</abbr>. <span class="cit-vol">32</span>:<span class="cit-fpage">513</span>–<span class="cit-lpage">545</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAnnu.%2BRev.%2BImmunol%26rft.volume%253D32%26rft.spage%253D513%26rft_id%253Dinfo%253Adoi%252F10.1146%252Fannurev-immunol-032713-120231%26rft_id%253Dinfo%253Apmid%252F24555472%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1146/annurev-immunol-032713-120231&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=24555472&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000336427400017&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text" id="ref-5">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.5" data-doi="10.1073/pnas.0603144103"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kamitani</span>  <span class="cit-name-given-names">W</span></span>, <span class="cit-auth"><span class="cit-name-surname">Narayanan</span>  <span class="cit-name-given-names">K</span></span>, <span class="cit-auth"><span class="cit-name-surname">Huang</span>  <span class="cit-name-given-names">C</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lokugamage</span>  <span class="cit-name-given-names">K</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ikegami</span>  <span class="cit-name-given-names">T</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ito</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kubo</span>  <span class="cit-name-given-names">H</span></span>, <span class="cit-auth"><span class="cit-name-surname">Makino</span>  <span class="cit-name-given-names">S.</span></span> <span class="cit-pub-date">2006</span>. <span class="cit-article-title">Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation</span>. <abbr class="cit-jnl-abbrev">Proc. Natl. Acad. Sci. U.S.A</abbr>. <span class="cit-vol">103</span>:<span class="cit-fpage">12885</span>–<span class="cit-lpage">12890</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DProc.%2BNatl.%2BAcad.%2BSci.%2BU.S.A%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.0603144103%26rft_id%253Dinfo%253Apmid%252F16912115%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMjoiMTAzLzM0LzEyODg1IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTcvMDgvMjkvMTgyMTk2LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text" id="ref-6">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.6" data-doi="10.1128/JVI.03535-14"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Zhang</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Li</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Cowley</span>  <span class="cit-name-given-names">TJ</span></span>, <span class="cit-auth"><span class="cit-name-surname">Steinbrenner</span>  <span class="cit-name-given-names">AD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Phillips</span>  <span class="cit-name-given-names">JM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Yount</span>  <span class="cit-name-given-names">BL</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baric</span>  <span class="cit-name-given-names">RS</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>. <span class="cit-pub-date">2015</span>. <span class="cit-article-title">The nsp1, nsp13, and M proteins contribute to the hepatotropism of murine coronavirus JHM.WU</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">89</span>:<span class="cit-fpage">3598</span>–<span class="cit-lpage">3609</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.03535-14%26rft_id%253Dinfo%253Apmid%252F25589656%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjk6Ijg5LzcvMzU5OCI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">7.</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text" id="ref-7">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.7" data-doi="10.1074/jbc.M704870200"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Devaraj</span>  <span class="cit-name-given-names">SG</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wang</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Chen</span>  <span class="cit-name-given-names">Z</span></span>, <span class="cit-auth"><span class="cit-name-surname">Chen</span>  <span class="cit-name-given-names">Z</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tseng</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Barretto</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lin</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Peters</span>  <span class="cit-name-given-names">CJ</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tseng</span>  <span class="cit-name-given-names">C-TK</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baker</span>  <span class="cit-name-given-names">SC</span></span>, <span class="cit-auth"><span class="cit-name-surname">Li</span>  <span class="cit-name-given-names">K.</span></span> <span class="cit-pub-date">2007</span>. <span class="cit-article-title">Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus</span>. <abbr class="cit-jnl-abbrev">J. Biol. Chem</abbr>. <span class="cit-vol">282</span>:<span class="cit-fpage">32208</span>–<span class="cit-lpage">32221</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BBiol.%2BChem%26rft_id%253Dinfo%253Adoi%252F10.1074%252Fjbc.M704870200%26rft_id%253Dinfo%253Apmid%252F17761676%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamJjIjtzOjU6InJlc2lkIjtzOjEyOiIyODIvNDQvMzIyMDgiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxNy8wOC8yOS8xODIxOTYuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text" id="ref-8">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.8" data-doi="10.1128/JVI.79.24.15189-15198.2005"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Barretto</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Jukneliene</span>  <span class="cit-name-given-names">D</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ratia</span>  <span class="cit-name-given-names">K</span></span>, <span class="cit-auth"><span class="cit-name-surname">Chen</span>  <span class="cit-name-given-names">Z</span></span>, <span class="cit-auth"><span class="cit-name-surname">Mesecar</span>  <span class="cit-name-given-names">AD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baker</span>  <span class="cit-name-given-names">SC</span></span>. <span class="cit-pub-date">2005</span>. <span class="cit-article-title">The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">79</span>:<span class="cit-fpage">15189</span>–<span class="cit-lpage">15198</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BVirology%26rft.stitle%253DJ.%2BVirol.%26rft.aulast%253DBarretto%26rft.auinit1%253DN.%26rft.volume%253D79%26rft.issue%253D24%26rft.spage%253D15189%26rft.epage%253D15198%26rft.atitle%253DThe%2BPapain-Like%2BProtease%2Bof%2BSevere%2BAcute%2BRespiratory%2BSyndrome%2BCoronavirus%2BHas%2BDeubiquitinating%2BActivity%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.79.24.15189-15198.2005%26rft_id%253Dinfo%253Apmid%252F16306590%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI3OS8yNC8xNTE4OSI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text" id="ref-9">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.9" data-doi="10.1073/pnas.0808790106"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chen</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Cai</span>  <span class="cit-name-given-names">H</span></span>, <span class="cit-auth"><span class="cit-name-surname">Pan</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Xiang</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tien</span>  <span class="cit-name-given-names">P</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ahola</span>  <span class="cit-name-given-names">T</span></span>, <span class="cit-auth"><span class="cit-name-surname">Guo</span>  <span class="cit-name-given-names">D.</span></span> <span class="cit-pub-date">2009</span>. <span class="cit-article-title">Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci USA</abbr> <span class="cit-vol">106</span>:<span class="cit-fpage">3484</span>–<span class="cit-lpage">3489</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DProc%2BNatl%2BAcad%2BSci%2BUSA%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.0808790106%26rft_id%253Dinfo%253Apmid%252F19208801%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMDoiMTA2LzkvMzQ4NCI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text" id="ref-10">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.10" data-doi="10.1128/JVI.00407-08"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Decroly</span>  <span class="cit-name-given-names">E</span></span>, <span class="cit-auth"><span class="cit-name-surname">Imbert</span>  <span class="cit-name-given-names">I</span></span>, <span class="cit-auth"><span class="cit-name-surname">Coutard</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bouvet</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Selisko</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Alvarez</span>  <span class="cit-name-given-names">K</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gorbalenya</span>  <span class="cit-name-given-names">AE</span></span>, <span class="cit-auth"><span class="cit-name-surname">Snijder</span>  <span class="cit-name-given-names">EJ</span></span>, <span class="cit-auth"><span class="cit-name-surname">Canard</span>  <span class="cit-name-given-names">B.</span></span> <span class="cit-pub-date">2008</span>. <span class="cit-article-title">Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">82</span>:<span class="cit-fpage">8071</span>–<span class="cit-lpage">8084</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00407-08%26rft_id%253Dinfo%253Apmid%252F18417574%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI4Mi8xNi84MDcxIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTcvMDgvMjkvMTgyMTk2LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">11.</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text" id="ref-11">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.11" data-doi="10.1016/j.chom.2012.04.011"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Zhao</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Jha</span>  <span class="cit-name-given-names">BK</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wu</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Elliott</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ziebuhr</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gorbalenya</span>  <span class="cit-name-given-names">AE</span></span>, <span class="cit-auth"><span class="cit-name-surname">Silverman</span>  <span class="cit-name-given-names">RH</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>. <span class="cit-pub-date">2012</span>. <span class="cit-article-title">Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-vol">11</span>:<span class="cit-fpage">607</span>–<span class="cit-lpage">616</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DCell%2BHost%2BMicrobe%26rft.aulast%253DZhao%26rft.auinit1%253DL.%26rft.volume%253D11%26rft.issue%253D6%26rft.spage%253D607%26rft.epage%253D616%26rft.atitle%253DAntagonism%2Bof%2Bthe%2Binterferon-induced%2BOAS-RNase%2BL%2Bpathway%2Bby%2Bmurine%2Bcoronavirus%2Bns2%2Bprotein%2Bis%2Brequired%2Bfor%2Bvirus%2Breplication%2Band%2Bliver%2Bpathology.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2012.04.011%26rft_id%253Dinfo%253Apmid%252F22704621%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2012.04.011&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22704621&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000305821800010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">12.</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text" id="ref-12">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.12" data-doi="10.1371/journal.ppat.1006195"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kindler</span>  <span class="cit-name-given-names">E</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gil-Cruz</span>  <span class="cit-name-given-names">C</span></span>, <span class="cit-auth"><span class="cit-name-surname">Spanier</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Li</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wilhelm</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rabouw</span>  <span class="cit-name-given-names">HH</span></span>, <span class="cit-auth"><span class="cit-name-surname">Züst</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hwang</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">V’kovski</span>  <span class="cit-name-given-names">P</span></span>, <span class="cit-auth"><span class="cit-name-surname">Stalder</span>  <span class="cit-name-given-names">H</span></span>, <span class="cit-auth"><span class="cit-name-surname">Marti</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Habjan</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Cervantes-Barragan</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Elliot</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Karl</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gaughan</span>  <span class="cit-name-given-names">C</span></span>, <span class="cit-auth"><span class="cit-name-surname">van Kuppeveld</span>  <span class="cit-name-given-names">FJM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Silverman</span>  <span class="cit-name-given-names">RH</span></span>, <span class="cit-auth"><span class="cit-name-surname">Keller</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ludewig</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bergmann</span>  <span class="cit-name-given-names">CC</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ziebuhr</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kalinke</span>  <span class="cit-name-given-names">U</span></span>, <span class="cit-auth"><span class="cit-name-surname">Thiel</span>  <span class="cit-name-given-names">V.</span></span> <span class="cit-pub-date">2017</span>. <span class="cit-article-title">Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication</span>. <abbr class="cit-jnl-abbrev">PLoS Pathog</abbr>. <span class="cit-vol">13</span>:<span class="cit-fpage">e1006195</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLoS%2BPathog%26rft.volume%253D13%26rft.spage%253De1006195%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.ppat.1006195%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.ppat.1006195&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">13.</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text" id="ref-13">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.13" data-doi="10.1073/pnas.0508200103"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Minskaia</span>  <span class="cit-name-given-names">E</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hertzig</span>  <span class="cit-name-given-names">T</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gorbalenya</span>  <span class="cit-name-given-names">AE</span></span>, <span class="cit-auth"><span class="cit-name-surname">Campanacci</span>  <span class="cit-name-given-names">V</span></span>, <span class="cit-auth"><span class="cit-name-surname">Cambillau</span>  <span class="cit-name-given-names">C</span></span>, <span class="cit-auth"><span class="cit-name-surname">Canard</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ziebuhr</span>  <span class="cit-name-given-names">J.</span></span> <span class="cit-pub-date">2006</span>. <span class="cit-article-title">Discovery of an RNA virus 3“-&gt;5” exoribonuclease that is critically involved in coronavirus RNA synthesis</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci USA</abbr> <span class="cit-vol">103</span>:<span class="cit-fpage">5108</span>–<span class="cit-lpage">5113</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DProc%2BNatl%2BAcad%2BSci%2BUSA%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.0508200103%26rft_id%253Dinfo%253Apmid%252F16549795%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMToiMTAzLzEzLzUxMDgiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxNy8wOC8yOS8xODIxOTYuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">14.</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text" id="ref-14">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.14" data-doi="10.1128/JVI.00542-16"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Case</span>  <span class="cit-name-given-names">JB</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ashbrook</span>  <span class="cit-name-given-names">AW</span></span>, <span class="cit-auth"><span class="cit-name-surname">Dermody</span>  <span class="cit-name-given-names">TS</span></span>, <span class="cit-auth"><span class="cit-name-surname">Denison</span>  <span class="cit-name-given-names">MR</span></span>. <span class="cit-pub-date">2016</span>. <span class="cit-article-title">Mutagenesis of SAdenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">90</span>:<span class="cit-fpage">7248</span>–<span class="cit-lpage">7256</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00542-16%26rft_id%253Dinfo%253Apmid%252F27252528%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI5MC8xNi83MjQ4IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTcvMDgvMjkvMTgyMTk2LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">15.</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text" id="ref-15">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.15" data-doi="10.1128/JVI.01296-07"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Eckerle</span>  <span class="cit-name-given-names">LD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lu</span>  <span class="cit-name-given-names">X</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sperry</span>  <span class="cit-name-given-names">SM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Choi</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Denison</span>  <span class="cit-name-given-names">MR</span></span>. <span class="cit-pub-date">2007</span>. <span class="cit-article-title">High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants</span>. <abbr class="cit-jnl-abbrev">J Virol</abbr> <span class="cit-vol">81</span>:<span class="cit-fpage">12135</span>–<span class="cit-lpage">12144</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.01296-07%26rft_id%253Dinfo%253Apmid%252F17804504%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4MS8yMi8xMjEzNSI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text" id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.16" data-doi="10.1371/journal.ppat.1003565"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">EC</span></span>, <span class="cit-auth"><span class="cit-name-surname">Blanc</span>  <span class="cit-name-given-names">H</span></span>, <span class="cit-auth"><span class="cit-name-surname">Vignuzzi</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Denison</span>  <span class="cit-name-given-names">MR</span></span>. <span class="cit-pub-date">2013</span>. <span class="cit-article-title">Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics</span>. <abbr class="cit-jnl-abbrev">PLoS Pathog</abbr> <span class="cit-vol">9</span>:<span class="cit-fpage">e1003565</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLoS%2BPathog%26rft.volume%253D9%26rft.spage%253De1003565%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.ppat.1003565%26rft_id%253Dinfo%253Apmid%252F23966862%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.ppat.1003565&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23966862&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text" id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.17" data-doi="10.1038/nm.2972"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Graham</span>  <span class="cit-name-given-names">RL</span></span>, <span class="cit-auth"><span class="cit-name-surname">Becker</span>  <span class="cit-name-given-names">MM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Eckerle</span>  <span class="cit-name-given-names">LD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bolles</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Denison</span>  <span class="cit-name-given-names">MR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baric</span>  <span class="cit-name-given-names">RS</span></span>. <span class="cit-pub-date">2012</span>. <span class="cit-article-title">A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease</span>. <abbr class="cit-jnl-abbrev">Nat Med</abbr> <span class="cit-vol">18</span>:<span class="cit-fpage">1820</span>–<span class="cit-lpage">1826</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNat%2BMed%26rft.volume%253D18%26rft.spage%253D1820%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnm.2972%26rft_id%253Dinfo%253Apmid%252F23142821%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nm.2972&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23142821&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text" id="ref-18">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.18" data-doi="10.1038/nature09605"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Qi</span>  <span class="cit-name-given-names">X</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lan</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wang</span>  <span class="cit-name-given-names">W</span></span>, <span class="cit-auth"><span class="cit-name-surname">Schelde</span>  <span class="cit-name-given-names">LM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Dong</span>  <span class="cit-name-given-names">H</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wallat</span>  <span class="cit-name-given-names">GD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ly</span>  <span class="cit-name-given-names">H</span></span>, <span class="cit-auth"><span class="cit-name-surname">Liang</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Dong</span>  <span class="cit-name-given-names">C.</span></span> <span class="cit-pub-date">2010</span>. <span class="cit-article-title">Cap binding and immune evasion revealed by Lassa nucleoprotein structure</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">468</span>:<span class="cit-fpage">779</span>–<span class="cit-lpage">783</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.aulast%253DQi%26rft.auinit1%253DX.%26rft.volume%253D468%26rft.issue%253D7325%26rft.spage%253D779%26rft.epage%253D783%26rft.atitle%253DCap%2Bbinding%2Band%2Bimmune%2Bevasion%2Brevealed%2Bby%2BLassa%2Bnucleoprotein%2Bstructure.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature09605%26rft_id%253Dinfo%253Apmid%252F21085117%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature09605&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21085117&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000285093700036&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text" id="ref-19">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.19" data-doi="10.1073/pnas.1016404108"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hastie</span>  <span class="cit-name-given-names">KM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kimberlin</span>  <span class="cit-name-given-names">CR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zandonatti</span>  <span class="cit-name-given-names">MA</span></span>, <span class="cit-auth"><span class="cit-name-surname">MacRae</span>  <span class="cit-name-given-names">IJ</span></span>, <span class="cit-auth"><span class="cit-name-surname">Saphire</span>  <span class="cit-name-given-names">EO</span></span>. <span class="cit-pub-date">2011</span>. <span class="cit-article-title">Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3“ to 5” exonuclease activity essential for immune suppression</span>. <abbr class="cit-jnl-abbrev">PNAS</abbr> <span class="cit-vol">108</span>:<span class="cit-fpage">2396</span>–<span class="cit-lpage">2401</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPNAS%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.1016404108%26rft_id%253Dinfo%253Apmid%252F21262835%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMDoiMTA4LzYvMjM5NiI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">20.</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20. in text" id="ref-20">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.20" data-doi="10.1128/JVI.01908-14"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Russier</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Reynard</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Carnec</span>  <span class="cit-name-given-names">X</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baize</span>  <span class="cit-name-given-names">S.</span></span> <span class="cit-pub-date">2014</span>. <span class="cit-article-title">The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">88</span>:<span class="cit-fpage">13811</span>–<span class="cit-lpage">13820</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.01908-14%26rft_id%253Dinfo%253Apmid%252F25253342%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4OC8yMy8xMzgxMSI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text" id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.21" data-doi="10.1128/JVI.03259-15"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Becares</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Pascual-Iglesias</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Nogales</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sola</span>  <span class="cit-name-given-names">I</span></span>, <span class="cit-auth"><span class="cit-name-surname">Enjuanes</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zuñiga</span>  <span class="cit-name-given-names">S.</span></span> <span class="cit-pub-date">2016</span>. <span class="cit-article-title">Mutagenesis of Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">90</span>:<span class="cit-fpage">5399</span>–<span class="cit-lpage">5414</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.03259-15%26rft_id%253Dinfo%253Apmid%252F27009949%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI5MC8xMS81Mzk5IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTcvMDgvMjkvMTgyMTk2LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22. in text" id="ref-22">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.22" data-doi="10.1128/JVI.00211-10"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Rose</span>  <span class="cit-name-given-names">KM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Elliott</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Martínez-Sobrido</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">García-Sastre</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>. <span class="cit-pub-date">2010</span>. <span class="cit-article-title">Murine coronavirus delays expression of a subset of interferon-stimulated genes</span>. <abbr class="cit-jnl-abbrev">J Virol</abbr> <span class="cit-vol">84</span>:<span class="cit-fpage">5656</span>– <span class="cit-lpage">5669</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00211-10%26rft_id%253Dinfo%253Apmid%252F20357099%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI4NC8xMS81NjU2IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTcvMDgvMjkvMTgyMTk2LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">23.</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23. in text" id="ref-23">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.23" data-doi="10.1073/pnas.1508686112"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Ma</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wu</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Shaw</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gao</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wang</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sun</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lou</span>  <span class="cit-name-given-names">Z</span></span>, <span class="cit-auth"><span class="cit-name-surname">Yan</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zhang</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rao</span>  <span class="cit-name-given-names">Z.</span></span> <span class="cit-pub-date">2015</span>. <span class="cit-article-title">Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex</span>. <abbr class="cit-jnl-abbrev">PNAS</abbr> <span class="cit-vol">112</span>:<span class="cit-fpage">9436</span>–<span class="cit-lpage">9441</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPNAS%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.1508686112%26rft_id%253Dinfo%253Apmid%252F26159422%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMToiMTEyLzMwLzk0MzYiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxNy8wOC8yOS8xODIxOTYuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text" id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.24"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Graepel</span>  <span class="cit-name-given-names">K</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lu</span>  <span class="cit-name-given-names">X</span></span>, <span class="cit-auth"><span class="cit-name-surname">Case</span>  <span class="cit-name-given-names">JB</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sexton</span>  <span class="cit-name-given-names">NR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">EC</span></span>, <span class="cit-auth"><span class="cit-name-surname">Denison</span>  <span class="cit-name-given-names">MR</span></span>. <span class="cit-pub-date">2017</span>. <span class="cit-article-title">Proofreading-deficient coronaviruses adapt over long-term passage for increased fidelity and fitness without reversion of exoribonuclease-inactivating mutations</span>. <abbr class="cit-jnl-abbrev">bioRxiv</abbr>.</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">25.</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25. in text" id="ref-25">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.25" data-doi="10.1128/JVI.05075-11"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Zhao</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rose</span>  <span class="cit-name-given-names">KM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Elliott</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Van Rooijen</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>. <span class="cit-pub-date">2011</span>. <span class="cit-article-title">Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">85</span>:<span class="cit-fpage">10058</span>–<span class="cit-lpage">10068</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.05075-11%26rft_id%253Dinfo%253Apmid%252F21752905%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4NS8xOS8xMDA1OCI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">26.</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26. in text" id="ref-26">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.26" data-doi="10.1128/JVI.00769-13"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Zhao</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Birdwell</span>  <span class="cit-name-given-names">LD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wu</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Elliott</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rose</span>  <span class="cit-name-given-names">KM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Phillips</span>  <span class="cit-name-given-names">JM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Li</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Grinspan</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Silverman</span>  <span class="cit-name-given-names">RH</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>. <span class="cit-pub-date">2013</span>. <span class="cit-article-title">Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">87</span>:<span class="cit-fpage">8408</span>–<span class="cit-lpage">8418</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00769-13%26rft_id%253Dinfo%253Apmid%252F23698313%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI4Ny8xNS84NDA4IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTcvMDgvMjkvMTgyMTk2LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">27.</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27. in text" id="ref-27">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.27"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Tomaselli</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Galeano</span>  <span class="cit-name-given-names">F</span></span>, <span class="cit-auth"><span class="cit-name-surname">Locatelli</span>  <span class="cit-name-given-names">F</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gallo</span>  <span class="cit-name-given-names">A.</span></span> <span class="cit-pub-date">2015</span>. <span class="cit-article-title">ADARs and the Balance Game between Virus Infection and Innate Immune Cell Response</span>. <abbr class="cit-jnl-abbrev">Curr Issues Mol Biol</abbr> <span class="cit-vol">17</span>:<span class="cit-fpage">37</span>–<span class="cit-lpage">51</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCurr%2BIssues%2BMol%2BBiol%26rft.volume%253D17%26rft.spage%253D37%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">28.</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28. in text" id="ref-28">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.28" data-doi="10.1089/jir.2009.0077"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Neil</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bieniasz</span>  <span class="cit-name-given-names">P.</span></span> <span class="cit-pub-date">2009</span>. <span class="cit-article-title">Human immunodeficiency virus, restriction factors, and interferon</span>. <abbr class="cit-jnl-abbrev">J. Interferon Cytokine Res</abbr>. <span class="cit-vol">29</span>:<span class="cit-fpage">569</span>–<span class="cit-lpage">580</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Binterferon%2B%2526%2Bcytokine%2Bresearch%2B%253A%2B%2Bthe%2Bofficial%2Bjournal%2Bof%2Bthe%2BInternational%2BSociety%2Bfor%2BInterferon%2Band%2BCytokine%2BResearch%26rft.stitle%253DJ%2BInterferon%2BCytokine%2BRes%26rft.aulast%253DNeil%26rft.auinit1%253DS.%26rft.volume%253D29%26rft.issue%253D9%26rft.spage%253D569%26rft.epage%253D580%26rft.atitle%253DHuman%2Bimmunodeficiency%2Bvirus%252C%2Brestriction%2Bfactors%252C%2Band%2Binterferon.%26rft_id%253Dinfo%253Adoi%252F10.1089%252Fjir.2009.0077%26rft_id%253Dinfo%253Apmid%252F19694548%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1089/jir.2009.0077&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=19694548&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000269855700011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">29.</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29. in text" id="ref-29">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.29" data-doi="10.2353/ajpath.2007.061088"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Gu</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Korteweg</span>  <span class="cit-name-given-names">C.</span></span> <span class="cit-pub-date">2007</span>. <span class="cit-article-title">Pathology and pathogenesis of severe acute respiratory syndrome</span>. <abbr class="cit-jnl-abbrev">Am. J. Pathol</abbr>. <span class="cit-vol">170</span>:<span class="cit-fpage">1136</span>–<span class="cit-lpage">1147</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAmerican%2BJournal%2BOf%2BPathology%26rft.stitle%253DAm.%2BJ.%2BPathol.%26rft.aulast%253DGu%26rft.auinit1%253DJ.%26rft.volume%253D170%26rft.issue%253D4%26rft.spage%253D1136%26rft.epage%253D1147%26rft.atitle%253DPathology%2Band%2BPathogenesis%2Bof%2BSevere%2BAcute%2BRespiratory%2BSyndrome%26rft_id%253Dinfo%253Adoi%252F10.2353%252Fajpath.2007.061088%26rft_id%253Dinfo%253Apmid%252F17392154%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.2353/ajpath.2007.061088&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=17392154&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000245233000002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">30.</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30. in text" id="ref-30">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.30" data-doi="10.1128/JVI.03036-15"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Birdwell</span>  <span class="cit-name-given-names">LD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zalinger</span>  <span class="cit-name-given-names">ZB</span></span>, <span class="cit-auth"><span class="cit-name-surname">Li</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wright</span>  <span class="cit-name-given-names">PW</span></span>, <span class="cit-auth"><span class="cit-name-surname">Elliott</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rose</span>  <span class="cit-name-given-names">KM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Silverman</span>  <span class="cit-name-given-names">RH</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>. <span class="cit-pub-date">2016</span>. <span class="cit-article-title">Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">90</span>:<span class="cit-fpage">3160</span>–<span class="cit-lpage">3172</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.03036-15%26rft_id%253Dinfo%253Apmid%252F26739051%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjk6IjkwLzYvMzE2MCI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">31.</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31. in text" id="ref-31">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.31" data-doi="10.1038/nature06042"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Malathi</span>  <span class="cit-name-given-names">K</span></span>, <span class="cit-auth"><span class="cit-name-surname">Dong</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gale</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Silverman</span>  <span class="cit-name-given-names">RH</span></span>. <span class="cit-pub-date">2007</span>. <span class="cit-article-title">Small self-RNA generated by RNase L amplifies antiviral innate immunity</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">448</span>:<span class="cit-fpage">816</span>–<span class="cit-lpage">819</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.aulast%253DMalathi%26rft.auinit1%253DK.%26rft.volume%253D448%26rft.issue%253D7155%26rft.spage%253D816%26rft.epage%253D819%26rft.atitle%253DSmall%2Bself-RNA%2Bgenerated%2Bby%2BRNase%2BL%2Bamplifies%2Bantiviral%2Binnate%2Bimmunity.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature06042%26rft_id%253Dinfo%253Apmid%252F17653195%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature06042&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=17653195&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000248754200042&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">32.</span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32. in text" id="ref-32">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.32" data-doi="10.1073/pnas.1201130109"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Bouvet</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Imbert</span>  <span class="cit-name-given-names">I</span></span>, <span class="cit-auth"><span class="cit-name-surname">Subissi</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gluais</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Canard</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Decroly</span>  <span class="cit-name-given-names">E.</span></span> <span class="cit-pub-date">2012</span>. <span class="cit-article-title">RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex</span>. <abbr class="cit-jnl-abbrev">Proc. Natl. Acad. Sci. U.S.A</abbr>. <span class="cit-vol">109</span>:<span class="cit-fpage">9372</span>–<span class="cit-lpage">9377</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DProc.%2BNatl.%2BAcad.%2BSci.%2BU.S.A%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.1201130109%26rft_id%253Dinfo%253Apmid%252F22635272%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMToiMTA5LzI0LzkzNzIiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxNy8wOC8yOS8xODIxOTYuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">33.</span><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33. in text" id="ref-33">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.33" data-doi="10.1038/ni.2236"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Lahouassa</span>  <span class="cit-name-given-names">H</span></span>, <span class="cit-auth"><span class="cit-name-surname">Daddacha</span>  <span class="cit-name-given-names">W</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hofmann</span>  <span class="cit-name-given-names">H</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ayinde</span>  <span class="cit-name-given-names">D</span></span>, <span class="cit-auth"><span class="cit-name-surname">Logue</span>  <span class="cit-name-given-names">EC</span></span>, <span class="cit-auth"><span class="cit-name-surname">Dragin</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bloch</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Maudet</span>  <span class="cit-name-given-names">C</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bertrand</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gramberg</span>  <span class="cit-name-given-names">T</span></span>, <span class="cit-auth"><span class="cit-name-surname">Pancino</span>  <span class="cit-name-given-names">G</span></span>, <span class="cit-auth"><span class="cit-name-surname">Priet</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Canard</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Laguette</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Benkirane</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Transy</span>  <span class="cit-name-given-names">C</span></span>, <span class="cit-auth"><span class="cit-name-surname">Landau</span>  <span class="cit-name-given-names">NR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kim</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Margottin-Goguet</span>  <span class="cit-name-given-names">F.</span></span> <span class="cit-pub-date">2012</span>. <span class="cit-article-title">SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates</span>. <abbr class="cit-jnl-abbrev">Nat. Immunol</abbr>. <span class="cit-vol">13</span>:<span class="cit-fpage">223</span>–<span class="cit-lpage">228</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2Bimmunology%26rft.stitle%253DNat%2BImmunol%26rft.aulast%253DLahouassa%26rft.auinit1%253DH.%26rft.volume%253D13%26rft.issue%253D3%26rft.spage%253D223%26rft.epage%253D228%26rft.atitle%253DSAMHD1%2Brestricts%2Bthe%2Breplication%2Bof%2Bhuman%2Bimmunodeficiency%2Bvirus%2Btype%2B1%2Bby%2Bdepleting%2Bthe%2Bintracellular%2Bpool%2Bof%2Bdeoxynucleoside%2Btriphosphates.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fni.2236%26rft_id%253Dinfo%253Apmid%252F22327569%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/ni.2236&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22327569&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">34.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-182196v1.34" data-doi="10.1038/nature10195"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hrecka</span>  <span class="cit-name-given-names">K</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hao</span>  <span class="cit-name-given-names">C</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gierszewska</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Swanson</span>  <span class="cit-name-given-names">SK</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kesik-Brodacka</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Srivastava</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Florens</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Washburn</span>  <span class="cit-name-given-names">MP</span></span>, <span class="cit-auth"><span class="cit-name-surname">Skowronski</span>  <span class="cit-name-given-names">J.</span></span> <span class="cit-pub-date">2011</span>. <span class="cit-article-title">Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">474</span>:<span class="cit-fpage">658</span>–<span class="cit-lpage">661</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.aulast%253DHrecka%26rft.auinit1%253DK.%26rft.volume%253D474%26rft.issue%253D7353%26rft.spage%253D658%26rft.epage%253D661%26rft.atitle%253DVpx%2Brelieves%2Binhibition%2Bof%2BHIV-1%2Binfection%2Bof%2Bmacrophages%2Bmediated%2Bby%2Bthe%2BSAMHD1%2Bprotein.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature10195%26rft_id%253Dinfo%253Apmid%252F21720370%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature10195&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21720370&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2017%2F08%2F29%2F182196.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000292204300043&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">35.</span><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference 35. in text" id="ref-35">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.35" data-doi="10.1007/s00018-016-2299-6"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Sanjuán</span>  <span class="cit-name-given-names">R</span></span>, <span class="cit-auth"><span class="cit-name-surname">Domingo-Calap</span>  <span class="cit-name-given-names">P.</span></span> <span class="cit-pub-date">2016</span>. <span class="cit-article-title">Mechanisms of viral mutation</span>. <abbr class="cit-jnl-abbrev">Cell. Mol. Life Sci</abbr>. <span class="cit-vol">73</span>:<span class="cit-fpage">4433</span>–<span class="cit-lpage">4448</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell.%2BMol.%2BLife%2BSci%26rft.volume%253D73%26rft.spage%253D4433%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs00018-016-2299-6%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1007/s00018-016-2299-6&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">36.</span><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference 36. in text" id="ref-36">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.36"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chen</span>  <span class="cit-name-given-names">W</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baric</span>  <span class="cit-name-given-names">RS</span></span>. <span class="cit-pub-date">1996</span>. <span class="cit-article-title">Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">70</span>:<span class="cit-fpage">3947</span>–<span class="cit-lpage">3960</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BVirology%26rft.stitle%253DJ.%2BVirol.%26rft.aulast%253DChen%26rft.auinit1%253DW.%26rft.volume%253D70%26rft.issue%253D6%26rft.spage%253D3947%26rft.epage%253D3960%26rft.atitle%253DMolecular%2Banatomy%2Bof%2Bmouse%2Bhepatitis%2Bvirus%2Bpersistence%253A%2Bcoevolution%2Bof%2Bincreased%2Bhost%2Bcell%2Bresistance%2Band%2Bvirus%2Bvirulence%26rft_id%253Dinfo%253Apmid%252F8648732%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjk6IjcwLzYvMzk0NyI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">37.</span><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37. in text" id="ref-37">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.37" data-doi="10.1128/JVI.76.21.11065-11078.2002"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Yount</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Denison</span>  <span class="cit-name-given-names">MR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weiss</span>  <span class="cit-name-given-names">SR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baric</span>  <span class="cit-name-given-names">RS</span></span>. <span class="cit-pub-date">2002</span>. <span class="cit-article-title">Systematic Assembly of a Full-Length Infectious cDNA of Mouse Hepatitis Virus Strain A59</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">76</span>:<span class="cit-fpage">11065</span>–<span class="cit-lpage">11078</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BVirology%26rft.stitle%253DJ.%2BVirol.%26rft.aulast%253DYount%26rft.auinit1%253DB.%26rft.volume%253D76%26rft.issue%253D21%26rft.spage%253D11065%26rft.epage%253D11078%26rft.atitle%253DSystematic%2BAssembly%2Bof%2Ba%2BFull-Length%2BInfectious%2BcDNA%2Bof%2BMouse%2BHepatitis%2BVirus%2BStrain%2BA59%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.76.21.11065-11078.2002%26rft_id%253Dinfo%253Apmid%252F12368349%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI3Ni8yMS8xMTA2NSI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE3LzA4LzI5LzE4MjE5Ni5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">38.</span><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38. in text" id="ref-38">↵</a><div class="cit ref-cit ref-journal" id="cit-182196v1.38" data-doi="10.1128/JVI.02805-06"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Donaldson</span>  <span class="cit-name-given-names">EF</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sims</span>  <span class="cit-name-given-names">AC</span></span>, <span class="cit-auth"><span class="cit-name-surname">Graham</span>  <span class="cit-name-given-names">RL</span></span>, <span class="cit-auth"><span class="cit-name-surname">Denison</span>  <span class="cit-name-given-names">MR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baric</span>  <span class="cit-name-given-names">RS</span></span>. <span class="cit-pub-date">2007</span>. <span class="cit-article-title">Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis</span>. <abbr class="cit-jnl-abbrev">J. Virol</abbr>. <span class="cit-vol">81</span>:<span class="cit-fpage">6356</span>–<span class="cit-lpage">6368</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.02805-06%26rft_id%253Dinfo%253Apmid%252F17392363%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI4MS8xMi82MzU2IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTcvMDgvMjkvMTgyMTk2LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div><a href="https://www.biorxiv.org/content/10.1101/182196v1.abstract" class="hw-link hw-link-article-abstract" data-icon-position="" data-hide-link-title="0">View Abstract</a></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-disqus-comment" >
  
      
  
  <div class="pane-content">
    <div id="disqus_thread"><noscript><p><a href="http://biorxivstage.disqus.com/?url=https%3A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F182196v1" class="" data-icon-position="" data-hide-link-title="0">View the discussion thread.</a></p></noscript></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><i class="icon-chevron-up"></i> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/10.1101/182212v1" title="Ecophylogenetics Reveals the Evolutionary Associations between Mammals and their Gut Microbiota" rel="prev" class="pager-link-prev link-icon"><i class="icon-circle-arrow-left"></i> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/10.1101/181784v1" title="Covert Shift of Attention Modulates the Value Encoding in the Orbitofrontal Cortex" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <i class="icon-circle-arrow-right"></i></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1" >
  
      
  
  <div class="pane-content">
    Posted&nbsp;August 29, 2017.  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-art-tools" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/10.1101/182196v1.full.pdf" target="_self" class="article-dl-pdf-link link-icon"><i class="icon-external-link-sign"></i> <span class="title">Download PDF</span></a>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/10.1101/182196v1.full" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for your interest in spreading the word about bioRxiv.</p><p>NOTE: Your email address is requested solely to identify you as the sender of this article.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/10.1101/182196v1" class="active" data-icon-position="" data-hide-link-title="0">Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from bioRxiv
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would like to see this page from the bioRxiv website.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/55028" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-YZr_xkcdTpSzdd25opOFBZT2UkR4LjCDjEGp4n-iFks" />
<input type="hidden" name="form_id" value="forward_form" />
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><i class="icon-share-alt"></i> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="55028" id="node55028--2" data-pisa="biorxiv;182196v1" data-pisa-master="biorxiv;182196" data-seqnum="55028" data-apath="/biorxiv/early/2017/08/29/182196.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">James Brett</span> <span class="nlm-surname">Case</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Yize</span> <span class="nlm-surname">Li</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Ruth</span> <span class="nlm-surname">Elliott</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Xiaotao</span> <span class="nlm-surname">Lu</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Kevin W.</span> <span class="nlm-surname">Graepel</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Nicole R.</span> <span class="nlm-surname">Sexton</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Everett Clinton</span> <span class="nlm-surname">Smith</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Susan R.</span> <span class="nlm-surname">Weiss</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">Mark R.</span> <span class="nlm-surname">Denison</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">182196; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/182196 </span></div>
  
  
  </div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://www.biorxiv.org/content/10.1101/182196v1" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://digg.com/submit?phase=2&amp;url=https%3A//www.biorxiv.org/content/10.1101/182196v1&amp;title=Mouse%20hepatitis%20virus%20nsp14%20exoribonuclease%20activity%20is%20required%20for%20resistance%20to%20innate%20immunity" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//www.biorxiv.org/content/10.1101/182196v1&amp;title=Mouse%20hepatitis%20virus%20nsp14%20exoribonuclease%20activity%20is%20required%20for%20resistance%20to%20innate%20immunity" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/182196v1&amp;text=Mouse%20hepatitis%20virus%20nsp14%20exoribonuclease%20activity%20is%20required%20for%20resistance%20to%20innate%20immunity" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//www.biorxiv.org/content/10.1101/182196v1&amp;title=Mouse%20hepatitis%20virus%20nsp14%20exoribonuclease%20activity%20is%20required%20for%20resistance%20to%20innate%20immunity" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//www.biorxiv.org/content/10.1101/182196v1&amp;t=Mouse%20hepatitis%20virus%20nsp14%20exoribonuclease%20activity%20is%20required%20for%20resistance%20to%20innate%20immunity" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//www.biorxiv.org/content/10.1101/182196v1&amp;title=Mouse%20hepatitis%20virus%20nsp14%20exoribonuclease%20activity%20is%20required%20for%20resistance%20to%20innate%20immunity" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//www.biorxiv.org/content/10.1101/182196v1&amp;title=Mouse%20hepatitis%20virus%20nsp14%20exoribonuclease%20activity%20is%20required%20for%20resistance%20to%20innate%20immunity" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools"><i class="icon-globe"></i> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="55028" id="node55028--3" data-pisa="biorxiv;182196v1" data-pisa-master="biorxiv;182196" data-seqnum="55028" data-apath="/biorxiv/early/2017/08/29/182196.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">James Brett</span> <span class="nlm-surname">Case</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Yize</span> <span class="nlm-surname">Li</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Ruth</span> <span class="nlm-surname">Elliott</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Xiaotao</span> <span class="nlm-surname">Lu</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Kevin W.</span> <span class="nlm-surname">Graepel</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Nicole R.</span> <span class="nlm-surname">Sexton</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Everett Clinton</span> <span class="nlm-surname">Smith</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Susan R.</span> <span class="nlm-surname">Weiss</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">Mark R.</span> <span class="nlm-surname">Denison</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">182196; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/182196 </span></div>
  
  
  </div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=Mouse%20hepatitis%20virus%20nsp14%20exoribonuclease%20activity%20is%20required%20for%20resistance%20to%20innate%20immunity&amp;rft.volume&amp;rft.issue&amp;rft.date=2017-01-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=bioRxiv&amp;rft.au=Case%2C+James+Brett&amp;rft.au=Li%2C+Yize&amp;rft.au=Elliott%2C+Ruth&amp;rft.au=Lu%2C+Xiaotao&amp;rft.au=Graepel%2C+Kevin+W.&amp;rft.au=Sexton%2C+Nicole+R.&amp;rft.au=Smith%2C+Everett+Clinton&amp;rft.au=Weiss%2C+Susan+R.&amp;rft.au=Denison%2C+Mark+R."></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/55028/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/55028/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/55028/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/55028/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/55028/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/55028/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/55028/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/55028/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/55028/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/55028/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/55028/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/55028/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><div class="item-list"><ul><li class="first"><a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/182196v1&amp;count=horizontal&amp;via=&amp;text=Mouse%20hepatitis%20virus%20nsp14%20exoribonuclease%20activity%20is%20required%20for%20resistance%20to%20innate%20immunity&amp;counturl=https%3A//www.biorxiv.org/content/10.1101/182196v1" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Tweet Widget</span></a></li><li><a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.biorxiv.org/content/10.1101/182196v1&amp;layout=button_count&amp;show_faces=false&amp;action=like&amp;colorscheme=light&amp;width=100&amp;height=21&amp;font=&amp;locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Facebook Like</span></a></li><li class="last"><a href="https://www.biorxiv.org/content/10.1101/182196v1" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Google Plus One</span></a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-collections" >
  
        <h2 class="pane-title">Subject Area</h2>
    
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-collections"><div class="highwire-list"><ul class="highwire-article-collection-term-list"><li class="first last odd"><span class="highwire-article-collection-term"><a href="/collection/microbiology" class="highlight" data-icon-position="" data-hide-link-title="0">Microbiology<i class="icon-caret-right"></i>
</a></span></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2" >
  
      
  
  <div class="pane-content">
    <div class="panel-flexible panels-flexible-8 clearfix" id="mini-panel-biorxiv_subject_collections">
<div class="panel-flexible-inside panels-flexible-8-inside">
<div class="panels-flexible-region panels-flexible-region-8-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-8-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
  
      
  <div class="snippet-content">
    <b>Subject Areas</b>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
  
      
  <div class="snippet-content">
    <a href="/content/early/recent"><strong>All Articles</strong></a>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-subject-collections" >
  
      
  
  <div class="pane-content">
    <ul id="collection" class="collection highwire-list-expand"><li class="outer collection depth-2  child first"><div class = "data-wrapper"><a href="/collection/animal-behavior-and-cognition" class="" data-icon-position="" data-hide-link-title="0">Animal Behavior and Cognition</a> <span class = "article-count">(1789)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biochemistry" class="" data-icon-position="" data-hide-link-title="0">Biochemistry</a> <span class = "article-count">(3141)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioengineering" class="" data-icon-position="" data-hide-link-title="0">Bioengineering</a> <span class = "article-count">(2136)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioinformatics" class="" data-icon-position="" data-hide-link-title="0">Bioinformatics</a> <span class = "article-count">(11098)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biophysics" class="" data-icon-position="" data-hide-link-title="0">Biophysics</a> <span class = "article-count">(4575)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cancer-biology" class="" data-icon-position="" data-hide-link-title="0">Cancer Biology</a> <span class = "article-count">(3584)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cell-biology" class="" data-icon-position="" data-hide-link-title="0">Cell Biology</a> <span class = "article-count">(5072)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/clinical-trials" class="" data-icon-position="" data-hide-link-title="0">Clinical Trials</a> <span class = "article-count">(137)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/developmental-biology" class="" data-icon-position="" data-hide-link-title="0">Developmental Biology</a> <span class = "article-count">(3114)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/ecology" class="" data-icon-position="" data-hide-link-title="0">Ecology</a> <span class = "article-count">(4915)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">Epidemiology</a> <span class = "article-count">(2044)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/evolutionary-biology" class="" data-icon-position="" data-hide-link-title="0">Evolutionary Biology</a> <span class = "article-count">(7708)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genetics" class="" data-icon-position="" data-hide-link-title="0">Genetics</a> <span class = "article-count">(5844)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genomics" class="" data-icon-position="" data-hide-link-title="0">Genomics</a> <span class = "article-count">(7321)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/immunology" class="" data-icon-position="" data-hide-link-title="0">Immunology</a> <span class = "article-count">(2735)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/microbiology" class="" data-icon-position="" data-hide-link-title="0">Microbiology</a> <span class = "article-count">(8398)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/molecular-biology" class="" data-icon-position="" data-hide-link-title="0">Molecular Biology</a> <span class = "article-count">(3345)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/neuroscience" class="" data-icon-position="" data-hide-link-title="0">Neuroscience</a> <span class = "article-count">(20276)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/paleontology" class="" data-icon-position="" data-hide-link-title="0">Paleontology</a> <span class = "article-count">(147)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">Pathology</a> <span class = "article-count">(529)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pharmacology-and-toxicology" class="" data-icon-position="" data-hide-link-title="0">Pharmacology and Toxicology</a> <span class = "article-count">(867)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/physiology" class="" data-icon-position="" data-hide-link-title="0">Physiology</a> <span class = "article-count">(1311)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/plant-biology" class="" data-icon-position="" data-hide-link-title="0">Plant Biology</a> <span class = "article-count">(3026)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/scientific-communication-and-education" class="" data-icon-position="" data-hide-link-title="0">Scientific Communication and Education</a> <span class = "article-count">(736)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/synthetic-biology" class="" data-icon-position="" data-hide-link-title="0">Synthetic Biology</a> <span class = "article-count">(976)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/systems-biology" class="" data-icon-position="" data-hide-link-title="0">Systems Biology</a> <span class = "article-count">(3039)</span></div></li>
<li class="outer collection depth-2  child last"><div class = "data-wrapper"><a href="/collection/zoology" class="" data-icon-position="" data-hide-link-title="0">Zoology</a> <span class = "article-count">(503)</span></div></li>
</ul>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__VNH5GD8Zz7g6_hGCOZjVjdMndxxC6naiExSSJKX3k_A__kzmEdtbqCsJx5Z9yg2Qy0PptB__ufXm-TxUOl0KZzUw__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js" defer="defer"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__llgGUcz2-k3Jmyyyog-_4yI1wJfGWwx0eQ2lbnM9IIo__t6UjIjIKIAD6nKc6BAU9qmlVV2VR4CBTNQbxlbJPgN0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
<script type="text/javascript" src="//d33xdlntwy0kbs.cloudfront.net/cshl_custom.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
  </body>
</html>
